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Background Postprandial hyperglycaemia is a risk factor for diabetes and its complications, 
and it is influenced by the rate of carbohydrate digestion and absorption. Human salivary 
amylase (HSA) initiates starch digestion in the mouth and plays an important role in starch 
digestion as it may continue starch digestion in the stomach during gradual gastric acidification. 
Previous research has shown that Hayward kiwifruit lowers the glycaemic response to co-
ingested cereal foods. However, the underlying mechanisms have not been identified; many 
factors, including acidity combined with the buffering capacity of fruit organic acids, and the 
action of the kiwifruit protease, actinidin, may play a part, and interact with one another during 
digestion.  
 
Aim To investigate effects of individual factors (fruit buffering capacity, acidity, pepsin and 
actinidin) and their interactions on HSA activity during 30 minutes of simulated gastric digestion 
and so to elucidate their role in the glycaemic response-lowering capacity of kiwifruit co-
ingested with cereal foods. 
 
Methods A semi-dynamic gastric model with automated titration was developed to mimic gastric 
digestion. This project had 6 stages: Stage 1: Determining the buffering capacity of various 
fruits. Stage 2: Development of a CaCl2 fortified potassium-citrate buffer to approximate kiwifruit 
organic acid (referred as Ca-KF buffer), and testing pH effects on HSA activity during gastric 
acidification to pH 2.0. Stage 3: determining effect of Hayward kiwifruit, SunGold kiwifruit and 
Granny Smith apple on HSA activity during acidification. Stage 4: Testing effect of pepsin on 
HSA activity during acidification. Stage 5: Determine interaction of pepsin and actinidin from 
Hayward kiwifruit on HSA activity during acidification. Stage 6: Measure effect of pepsin with the 
three fruits in stage 3 on HSA activity in a Weet-Bix™ meal. HSA activity was measured as 
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sugar released in 15 and 30 minutes using a colorimetric assay. Protein analysis by SDS-PAGE 
and a kinetic assay were used to examine effects of pepsin-actinidin interaction on HSA survival 
in stage 5.  
 
Results Buffering capacity differed between fruits. HSA activity decreased as pH dropped from 
7.0 to 2.0 with little decrease in activity above pH 4.0. The Ca-KF buffer significantly inhibited 
HSA activity at a pH range of 3.0 to 6.0 (p<0.01) compared to CaCl2 fortified saline solution. 
Pepsin inhibited HSA activity at pH 4.0 and below. Hayward kiwifruit significantly inhibited HSA 
activity at pH 4.0 and below (p<0.01) with the strongest inhibition at pH 4.0. A significant but 
small inhibition was contributed by SunGold kiwifruit (p<0.01) as well as Granny Smith apple 
(p<0.05) at pH 3.0 and below. HSA activity was inhibited more by pepsin alone than by pepsin 
and actinidin combined at pH 3.0 and below. Actinidin inhibited HSA activity more than pepsin 
alone at pH 4.0.  
 
Conclusion The low pH and strong buffering capacity of kiwifruit lead to immediate inhibition of 
HSA activity in the stomach as well as promoting early activation of pepsin, which also 
inactivates HSA. Actinidin in Hayward kiwifruit actively degraded HSA at its optimal pH around 
4.0 but pepsin degraded both actinidin and HSA when pH fell below 3.0. Overall, Hayward 
kiwifruit had a potential in retarding HSA in the stomach and in turn might lower glycaemic 
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In 2017, the International Diabetes Federation (IDF) reported a high prevalence of diabetes with 
425 million adults (1 in 11 adults) worldwide diagnosed with the condition, while 50% of cases 
remain undiagnosed (1).  The majority (90%) of cases are type 2 diabetes mellitus (T2DM) (2). 
Diabetes is estimated to contribute to 4 million early deaths annually and to cost 12% of the 
global health expenditure (727 billion USD) (1) as a result of ill health caused by direct and 
indirect effects of elevated blood sugar, which is a defining feature of diabetes. Given its 
enormous burden on mortality, morbidity and health economics (3), it is important to manage 
diabetes by controlling blood glucose, dietary and lifestyle factors which are important elements 
of blood glucose management especially for those who suffer from T2DM (4).  
 
T2DM is a chronic metabolic disorder characterised by persistent hyperglycaemia due to a 
combination of pancreatic β-cell dysfunction and insulin resistance (5). Major risk factors for 
T2DM are obesity (6), sedentary lifestyle (7) and ageing (8). Additionally, diets with high 
glycaemic index (GI) and load (GL) have been found to be associated with risk (9). Studies on 
GI and GL have revealed a positive relationship between the in vivo rate of carbohydrate 
digestion and the glycaemic response to ingesting carbohydrate-containing foods (10-12). 
Starch is the main digestible carbohydrate in the human diet and abundant in staple foods such 
as potatoes, beans and cereals such as maize and rice, etc. (13). Understanding parameters 
governing the rate of starch digestion and associated glycaemic response is key to moderating 
the impact of diet on blood glucose in T2DM management.  
 
Human salivary α-amylase (HSA) initiates starch breakdown in the mouth and its action 
continues in the stomach before the breakdown products and remaining starch enter the small 
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intestine for more complete hydrolysis by pancreatic α-amylase and brush border enzymes (13) 
before absorption. HSA is a major digestive enzyme in human saliva that breaks down amylose 
and amylopectin by cleaving α-1,4-glycosidic bonds (14). The enzyme has optimal activity at a 
pH around 5.0 at a temperature of 37 °C (15). Given the limited contact time that saliva has with 
foods in the mouth and its inactivation in an acidic stomach environment, the significance of 
HSA in starch hydrolysis was often thought to be negligible compared to pancreatic amylase 
(16-18). However, studies back in the 1900s found HSA activity in human duodenal juice 
suggesting the intact passage of HSA through the stomach and even reaching the duodenum 
(19-21). More evidence has led to the speculation that HSA is able to pass through the gut 
intact under protection of starch oligosaccharides and other dietary components, while 
hydrolysing a substantial amount of starch (20, 22, 23). 
 
In the stomach, masticated food contents, so called boluses, are chemically and physically 
disintegrated by gastric secretions and gastric peristalsis to form chyme which is periodically 
emptied into the small intestinal for neutralization and further digestion at the pH optimum of the 
pancreatic amylases. (24). Although gastric acid has a pH close to 2.0, acidification generally 
starts at a higher pH and gradually declines to below 4.0, which inactivates HSA in up to 45 min 
depending on food contents (25). Therefore, food compositions and buffering capacity are 
important determinants of gastric acidification, continued HSA activity, and gastric emptying 
(GE) (26), and subsequent digestion and absorption in the small intestine (27).  
 
Incorporating organic acid into foods (e.g., breads enriched with lactic acid) or co-consuming it 
with other foods (e.g., vinegar dressing on starchy foods) has been found to lower postprandial 
glycaemic response and attributed to delayed GE (28, 29). With a high content of vitamin C and 
a range of other organic acids, as well as dietary fibre, kiwifruit has been found to have healthful 
qualities (30). The non-sugar components of kiwifruit have been found to exhibit a glycaemic 
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response-lowering effect on co-ingested carbohydrates during in vivo gastrointestinal digestion 
(31). This suppression of glycaemic response by kiwifruit is possibly due to the acidity of the fruit 
combined with the buffering capacity of its organic acids (31), with a possible contribution from 
dietary fibre and various phytochemicals. In addition, the natural protease actinidin may play a 
role by degrading HSA.    
 
Green kiwifruit (Actinidia deliciosa cv. Hayward) in particular is abundant in actinidin, which 
digests a broad range of proteins including HSA at its optimum pH around 4.0 (32). Limited but 
clear evidence has demonstrated that actinidin from green kiwifruit extracts is able to enhance 
gastric digestion and GE of a number of large dietary proteins (Molecular Weight>30 kDa) in 
vitro (33) and in rat and pig models (34, 35). However, little is known about the role of pH in 
gastric digestion involving kiwifruit except one recent study reported kiwifruit actinidin exerted 
little influence on gastric protein digestion when the pH was below 3.1 (36).  
 
Several gaps in the literature can be identified. Firstly, evidence of the effect of pH on prolonged 
salivary digestion of starch that occurs under postprandial conditions in the stomach is scarce, 
with little attention given to the effect of gradual pH change on enzymes. Only Freitas’ (24) 
gastric model has accounted for the physiological fact that stomach digestion starts at a near 
neutral pH and gradually acidifies. Secondly, little evidence is available to help to define and 
quantify the buffering capacity of kiwifruit that may be responsible for delaying GE (31). 
Moreover, little is known about the degradation of HSA by kiwifruit actinidin and pepsin, 
respectively, or how the interaction of actinidin with pepsin affects HSA survival under gastric 
conditions.  
 
This masters project aimed to explore the role of kiwifruit components on starch digestion in the 
stomach using a semi dynamic model to monitor effect of changing gastric pH on HSA activity. 
4 
 
The research is novel in several respects: (1) measuring the effects of kiwifruit on gastric pH 
and buffering capacity, and comparing its buffering capacity with that of other fruits; (2) 
monitoring gastric activity of HSA at changing pH; (3) measuring gastric activity of HSA in the 
presence of the kiwifruit protease actinidin; (4) investigating the interaction of pepsin with 
actinidin and effect of the interaction on gastric survival of HSA. The project consisted of 6 
stages starting from looking at individual factors (i.e. fruit buffering capacity, pH, pepsin, 
actinidin) on HSA activity under gastric conditions to the combination of multiple factors so that 
the mechanism can be understood step by step.  
 
The hypotheses guiding the research were: (1) Organic acids in fruit lead to postprandial gastric 
acidification while conferring a buffering capacity that is different among fruits (i.e. green 
kiwifruit, gold kiwifruit, berries, apples and orange); (2) Starch hydrolysis by HSA in the stomach 
changes as a function of gastric pH; (3) HSA activity in the stomach is sufficient to extensively 
degrade starch before inactivation by changing pH; (4) HSA is degraded by pepsin as a function 
of pH; (5) HSA is degraded by kiwifruit actinidin as a function of pH; (6) the interaction of pepsin 
with actinidin under gastric conditions affects their joint degradation of HSA and is pH 
dependent. By addressing the foregoing hypotheses, the proposed research will help to clarify 
the possible role of organic acids, pH and actinidin activity in retarding the postprandial gastric 
degradation of ingested starch by HSA. By so doing it may help to identify their contribution to 
the ability of kiwifruit to reduce the glycaemic response to co-consumed starchy cereal in an 
equal carbohydrate exchange format. That is, it may support a role for kiwifruit in a healthy diet 




2. Literature Review 
 
This literature review discusses the effect of pH, and some kiwifruit components, on HSA 
activity under gastric conditions. It identifies gaps in our knowledge by providing an overview 
and analysis of the following topics:   
➢ Importance of glycaemic response in diabetes 
➢ Role of starch digestion in the glycaemic response 
➢ Significance of HSA in starch digestion and survival in the gut 
➢ Impact of kiwifruit organic acids and actinidin on gastric HSA activity 
➢ Effect of kiwifruit in gastric digestion of starch with regards to GE 
 
2.1. Search strategy  
 
The literature search was carried out on Web of Science and Google Scholar using key words 
“glycaemic response”, “diabetes”, “salivary amylase”, “starch digestion”, “gastric digestion”, 
“gastric acidification”, “buffering capacity”, “gastric emptying”, “organic acids”, “citric acid”, 
“actinidin” and “pepsin”. Additional literature was obtained from reference lists and cross-
references in published articles.  
 
2.2. Glycaemic response and diabetes 
 
The main burden of ill health associated with diabetes is well established as being the direct and 
indirect result of elevated blood glucose concentrations, both postprandial and chronic (2). 
Elevated postprandial blood glucose is thought to contribute to the syndromic character of 
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diabetes and its complications through combinations of several mechanisms, including 
exhaustion of β-cell function in the pancreas due to excessive insulin demand, non-specific 
glycation of biomolecules throughout the body, and indirect widespread damage and loss of 
immune function due to hyperglycaemia-induced oxidative stress (37). 
 
In addition to its role in the health consequences of diabetes, hyperglycaemia may also play a 
role as an antecedent to diabetes through its contribution to obesity, which is one of the major 
risk factors for diabetes (6). Rapid digestion of starchy foods may contribute to obesity through a 
coupling of acute insulin response with postprandial glycaemia favouring lipogenesis and lack of 
satiety due to rapid food digestion (38). Therefore, the rate of starch digestion is a critical factor 
in dietary management of both the risk and consequences of diabetes. 
 
Unlike type 1 diabetes mellitus (T1DM), T2DM is a non-insulin-dependent disease that is 
developed later in life and attributed to risk factors such as ageing (8), overweight and obesity 
(6), sedentary lifestyle (39) and unhealthy diets (9). The latest report by the International 
Diabetes Federation (IDF) on the global prevalence of diabetes claimed that in 2017, 425 million 
adults aged 20 to 79 years old around the world suffered from diabetes, with a mortality of 4 
million lives and a cost of 727 billion USD of health expenditure because of hyperglycaemia and 
related complications, such as hypertension and cardiovascular disease (1). Almost half of the 
diabetic population was unaware of their condition (1) and 90% of them suffered from T2DM (2). 
Improving lifestyle and dietary factors to maintain a normal blood glucose level are important 
approaches to T2DM management and prevention, especially in developing countries where 




2.3. Starch digestion 
 
Starch comprises a large proportion of dietary carbohydrate, consumed in the form of potatoes, 
corn, rice, legumes and other cereals(13). Starch is made up of glucose residues linked by α-
1,4-glycosidic bonds in linear segments and α-1,6-glycosidic bonds at branch points (15), and 
generally consists of 20-30% amylose (linear) and 70-80% amylopectin (branched). The 
compact linear structure of amylose makes it less accessible to α-amylase than amylopectin so 
it is more slowly hydrolysed than amylopectin (40). HSA produced by the salivary glands 
initiates starch digestion in the oral cavity by hydrolysing starch into smaller oligosaccharides 
while food is transformed into a bolus through mastication (24). Within a minute of ingestion 
(depending on variables such as food quantity, texture and flavour), boluses are swallowed and 
enter the stomach, where they are physically and chemically broken down, weakened by 
enzyme activities in gastric secretions at low pH and disintegrated by peristaltic contractions of 
the stomach wall, before being periodically emptied to the duodenum as chyme (24, 41). In the 
small intestine, pancreatic amylase and brush border enzymes complete the hydrolysis of starch 
and oligosaccharides to glucose for absorption into the bloodstream (15). Elevated blood 
glucose level triggers the release of insulin by pancreatic 𝛽-cells which facilitates glucose 
uptake by cells and lower blood glucose (5).  
 
2.3.1. Rate of starch digestion and glycaemic control 
 
As sugar release from dietary carbohydrates is the direct cause of rise in blood glucose, a 
knowledge of how carbohydrates, in this instance starch, are digested is key to glycaemic 
control. Several lines of evidence have indicated that the rate of digestion is an important factor 
of glycaemic response to foods (9-12). It has been found that the intrinsic digestibility of starch 
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in foods, measured by in vitro digestive analysis with pancreatic amylase, predicts glycaemic 
response to carbohydrate in foods when the foods are consumed by humans (42). In an 
randomised crossover trial, Ells et al (10) found that slowly digestible starch (~90% glucose 
released in 70 min in vitro) evoked a slower and more sustained rise in blood glucose compared 
to rapidly digestible starch (~90% glucose released in 10 min in vitro) which resulted in a sharp 
rise and fall in blood glucose.  
 
Glycaemic index (GI) and glycaemic load (GL) provide measurements of the relative blood 
glucose raising ability of a fixed amount of carbohydrate in foods (GI) and when whole foods are 
eaten in variable amounts (GL). Both GI and GL are reported to be positively associated with 
risk of T2DM in a meta-analysis of 21 cohort studies (9). However, the data are not consistent 
as in three prospective studies, no significant associations were found between these dietary 
factors and risk of T2DM (43-45) while in two other studies, a positive association was found 
with GI but not GL (12, 46). Given the nature of observational studies, these results should be 
interpreted with caution. A meta-analysis of 10 randomised control trials (RCTs) showed low GI 
diets had marginal benefit on glycaemic control in diabetic patients by reducing medium-term 
glycated haemoglobin (HbA1c) levels (47). This was agreed by another meta-analysis of 6 
recent RCTs which demonstrated significant difference (p<0.001) between low and high GI diets 
in HbA1c levels in patients with T2DM (48). However, a recent meta-analysis involving 185 
prospective studies and 58 clinical trials revealed a weak association between dietary GI and 
GL with health (49). More large-scale RTCs are needed to verify the long-term effect of low GI 





2.4. Human salivary α-amylase (HSA) 
 
HSA (α-1,4-α-D-glucan glucanohydrolase; EC 3.2.1.1) is a major digestive enzyme in human 
saliva and accounts for 40-50% of salivary protein (50). This enzyme has a molecular weight of 
56 kDa in its non-glycosylated form and 62 kDa in its glycosylated form (51). HSA consists of a 
single polypeptide chain of 496 amino acids folded into three domains (A, B and C) with the 
active site located in a (𝛽/𝛼)8-barrel in Domain A (52). In catalytic action, HSA cleaves α-1,4-
glycosidic bonds in amylose and amylopectin yielding maltose, maltotriose and α-dextrin (14).  
 
2.4.1. AMY1 gene copy number variation 
 
HSA production and enzymatic activity levels vary among and within individuals and are 
subjected to regulation by environmental factors such as circadian rhythms (53) and physical 
and psychological stress (54).  Genetic factors also account for between-person variability as 
copy number (CN) of the HSA coding gene AMY1 varies from 1 to 15 among individuals (55). A 
positive correlation between AMY1 gene CN and its expression and activity has been 
demonstrated in previous studies (55-57) although evidence on determinants of variation in 
AMY1 CN is mixed (55, 57-59). Perry et al (57) reported a significantly larger CN of AMY1 gene 
in populations historically fed on a high-starch diet (e.g., European Americans and Japanese) 
than that of populations on a low-starch diet (e.g., rainforest hunter-gatherers and Yakutians) 





2.4.2. HSA survival in the gut 
 
Evidence for an impact of HSA on starch digestion is mixed, which is understandable given the 
short duration of the oral phase of digestion, and deactivation of HSA by gastric acidity. HSA 
activity has an optimum pH range of 5.0 to 7.0 (15, 60). Fried et al (19) reported that inactivation 
of HSA was observed by a gastric pH between 3.8 and 3.3 in vitro and pH 3.0 and below in vivo. 
However, HSA is unlikely to become inactivated immediately upon entering the stomach, as 
adjustment of the gastric pH after consuming a solid-liquid meal (pH~6.7) to the fasted state 
(pH~1.7) took approximately 2 hours (25). Gastric acidification is therefore a gradual process, 
taking 45 to 60 minutes to reduce the pH to below pH 4.0, depending on the meal composition 
and its initial pH (61).  
 
A few early human studies in the 1900s provided evidence for researchers to speculate that 
HSA may still remain active while passing through the gastrointestinal tract (19, 21). Bergeim 
(20) reported that up to 76% and 59% of starch in mashed potatoes and bread respectively, was 
hydrolysed in the stomach. Little is known about the mechanism behind passage of intact HSA 
through the stomach. Skude et al (21) found HSA activity was present in over 75% of duodenal 
aspirate samples and accounted for 15% and 40% of total amylase activity in normal subjects 
and chronic pancreatitis patients, respectively (21). Similar observations were made by Fried et 
al (19) who estimated that HSA accounted for 11% of total amylase in duodenal samples of a 
normal subject compared to 27% of that in an achlorhydric subject after a hamburger meal. In 
addition, the hydrolytic products of dietary components might in part protect HSA from gastric 
inactivation (19). This hypothesis was supported by Rosenblum et al (22) who found in in vitro 
studies that 1% starch was able to preserve 56% of HSA activity after 60 min exposure to pH 
3.0 at 37 ⁰C and up to 5% maltose and maltotriose also conferred significant protection of HSA 
activity against low pH.  
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2.4.3. A dynamic gastric model investigating role of HSA in starch digestion 
 
An extensive amount of work has been done investigating the kinetics of starch digestion in vitro 
with little attention given to the oral digestion or gastric digestion processes (11, 17, 60, 62-64). 
Only Freitas et al (60) has used a dynamic gastric model which not only accounted for the effect 
of the oral phase on starch hydrolysis but also mimicked postprandial gastric digestion during a 
change in pH from 6.0 to 2.0. The oral phase of Freitas et al. simulated mastication by mixing 
saliva (collected from a non-smoker) with artificially chewed wheat bread crumbs. In vivo oral 
digestion was performed in the same fashion but chewed by the same person who supplied 
saliva. Four types of gastric digestions were conducted testing two digestion circumstances 
(snack and lunch) with water and inactivated pepsin as controls. (1) snack-type digestion of a 
water-based bolus (SWB, 30 min digestion at pH 6.0 to 2.0 plus 30 min at constant pH 2.0); (2) 
snack-type digestion of a saliva-based bolus (SSB, same as SWB); (3) lunch-type digestion of a 
saliva-based bolus (LSB, 60 min digestion at pH 6.0 to 2.0 plus 30 min at constant pH 2.0); (4) 
constant pH digestion of a saliva-based bolus (CSB, 60 min digestion at constant pH 6.0). 
Gastric digestion was performed using DiDGI® with continuous HCl and pepsin influx and 
stirring at 37 ⁰C.  
 
Amylolytic activity of saliva as a function pH revealed that HSA exerted maximal activity at pH 
6.0 to 7.0 but lost 50% activity at pH 4.0 and was completely inactivated at pH 3.5. These 
findings were in line with other observations (15, 19). Boluses produced in vitro and in vivo were 
highly comparable in their response to HSA digestion, indicating that in vitro HSA digestion 
could closely mimic that of oral digestion of starch. Compared to earlier gastric models 
processing at a stable acidic pH (11, 63, 64), Freitas’s model presented a more realistic picture 
of starch digestion in oral and gastric phases. Similar trends in glucose release (80% starch 
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released in 20 min digestion) were observed in both snack and lunch type digestions, clearly 
showing the important role of HSA activity in the stomach in the overall digestion of starch.  
 
2.5. Interaction of kiwifruit with HSA 
 
Recent research by Mishra et al (31) has indicated that a lowering of glycaemic response when 
kiwifruit is partially exchanged for cereal, on an equal carbohydrate basis, is due to more than 
simple substitution of kiwifruit sugars for cereal starch. When cereal was consumed either with 
kiwifruit sugars alone, or with the whole kiwifruit containing the same amount of sugars, 
glycaemic response was lower with the whole kiwifruit (31). This showed that there were 
components other than sugars in the kiwifruit that could lower glycaemic response to starchy 
foods when co-ingested with kiwifruit. 
 
The non-sugar factors in kiwifruit responsible for the lowering of glycaemic response could 
include retardation of digestion due to the effects of kiwifruit dietary fibre on the physical 
properties of the gastric chyme (65), and inhibition of glucose uptake by phenolics from kiwifruit 
(66). However, in light of recent reports on the possible importance of HSA in starch digestion 
and glycaemic response (23, 60), another possibility is that the kiwifruit could be inhibiting the 
digestion of starch by HSA in the stomach. 
 
There are several ways in which kiwifruit might inhibit HSA, or reduce its effects in the stomach: 
 
• Kiwifruit organic acids may rapidly reduce the pH of the gastric chyme to below the 
optimum pH range for HSA activity. 
• The organic acids, citric acid in particular, may directly inhibit HSA activity. 
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• The kiwifruit protease actinidin may degrade HSA. 
• The reduction in pH due to the kiwifruit organic acids may stimulate the activity of the 
gastric protease, pepsin, which may interact with the kiwifruit actinidin and degrade HSA. 
• The effect of low pH and buffering due to the kiwifruit organic acids may cause a delay in 
GE, which delay the arrival of carbohydrates at the sites of glucose absorption in the 
small intestine. 
 
Gastric digestion is governed by a range of food-related factors such as food composition and 
buffering as well as psychological factors such as gastric secretions and GE (24). The effect of 
kiwifruit on HSA activity in the stomach is complicated by the fact that the above factors will all 
interact. In particular, actinidin and pepsin, both being proteases, may degrade one another with 
surviving activity depending on the pH at which the interaction occurs.  
 
2.5.1. Kiwifruit organic acids 
 
Kiwifruit is a good source of ascorbic acid (Vitamin C), ranging from 50 to 430 mg per 100 g 
fresh weight (FW) depending on the cultivar, for instance, SunGold kiwifruit of Zespri contains 
nearly three times the concentration of Vitamin C than that in oranges (161 mg/100 g FW and 
51 mg/100 g FW, respectively) (67). There are a range of other organic acids in kiwifruit 
including citric acid, quinic acid and malic acid. The compositions of most organic acids are 
similar across different kiwifruit cultivars analysed except that quinic acid is present in higher 
concentration in gold kiwifruit (Actinidia deliciosa cv. ‘Hort16A’) than in green kiwifruit (Actinidia 





The presence of organic acids is the main cause of fruit acidity. There has been little research 
on the influence of organic acids on the activity of HSA in the stomach, presumably because the 
activity of HSA in gastric digestion has for many years been thought to be unimportant. 
However, Freitas et al (60) found that a gradual rate of change in gastric acidification provided 
the opportunity for HSA to rapidly hydrolyse a large proportion of starch until the pH had 
reduced to the point where the enzyme had been inactivated. Freitas et al (69) plotted the 
dependence of HSA on pH showing activity decreased as the pH was reduced. Thus, they 
proposed that reducing HSA activity through premature acidification could slow down amylolysis 
and reduce glycaemic response to starchy foods. This was demonstrated by inhibited HSA 
activity by lemon juice in vitro. Lemon juice, which lowered the pH of chyme to ~ 2.5 significantly 
reduced starch release in bread to 35% compared with 84% in water (pH ~ 6.0) at the end of in 
vitro gastric digestion (69). In addition, the protective effect of oligosaccharides on HSA at low 
pH proposed by Rosenblum et al (22) was not observed in this case, indicating acidification by 
co-ingestion of acidic foods could be an effective approach to reduce oro-gastric hydrolysis of 
starch and ultimately glycaemic response of starchy foods.  
 
Abundant in organic acids, kiwifruit has a low pH of 3.0-3.5 depending on cultivar, orchard and 
time of harvest (70). Previous research by Mishra et al (31) demonstrated that green kiwifruit 
(200 g pulp, pH 3.3) lowered the pH of co-ingested breakfast cereal (47.3 g, pH 5.3) to 3.7, 





2.5.3. Citric acid  
 
It has been shown that citric acid can inhibit HSA activity (71), possibly because HSA requires 
Ca2+ ions as cofactors for enzymatic activity while citric acid is a chelating agent which reduces 
the availability of free and functional Ca2+ to HSA (52). A forensic saliva identification study 
showed a significant decrease (p<0.05) of 92.2% and 99.7% in HSA activity in saliva samples 
contaminated with citric acid-containing soft drinks (8.7 mg and 7.1 mg of citric acid/L, 
respectively) (71). Therefore, organic acids could inhibit HSA both through their binding of Ca2+ 
by citric acid as well as their effects on pH.  
 
2.5.4. Kiwifruit actinidin  
 
Actinidin (EC 3.4.22.14) is a cysteine protease comprising up to 40% of soluble proteins in 
green kiwifruit but less than 1% in gold cultivars (72, 73). Actinidin consists of a single 
polypeptide chain of 220 amino acid residues with a molecular weight (MW) of 23 kDa and 
appears as a band somewhere at 24-30 kDa on SDS-PAGE gel (74). Other major proteins in 
kiwifruit identified include kiwellin (28 kDa on PAGE), thaumatin-like protein (24 kDa on PAGE) 
and kirola (17 kDa on PAGE) (74, 75). Actinidin contains a free sulfhydryl bond in its structure 
that is essential for its activity but also makes it susceptible to oxidation (33).  
 
Actinidin catalyses the hydrolysis of a broad range of proteins at a pH range of 3.0 to 6.0 with an 
optimum of 4.0 (76). The interaction between actinidin and HSA had not been explored until one 
recent study by Martin et al (32) in which actinidin was shown to be highly active against HSA. 
Five minutes of exposure to green kiwifruit containing actinidin at 37 °C resulted in 83% loss of 
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HSA activity as assessed a colorimetric assay and 64% loss using potato starch as substrate 
(32).   
 
2.6. Pepsin  
 
Pepsin is a principle digestive enzyme responsible for partial digestion of proteins into smaller 
peptides in the stomach. Pepsin consists of 330-350 amino acids residues and has a MW of 35 
kDa (77). Its zymogen, pepsinogen, is secreted by chief cells on gastric mucosa and activated 
at low pH upon HCl release by parietal cells (77). Determinations of pH optimum of pepsin have 
varied slightly depending on substrate and buffer used, but most studies (78-81) have found that 
pepsin activity was maximal at pH 1.5 to 2.0 and minimal at pH 5.0 and above. Piper and 
Fenton (81) plotted a composite profile of pH activity and stability of pepsin (Figure 1) showing 
that human pepsin exerted maximal activity at pH 2.0 and started to lose activity as pH 
increased until it lost activity at pH 5.5 and became irreversibly inactivated at pH 7.5 and above. 
It was also revealed that pepsin was stable at pH 1.0 to 6.0, a range where peptic activity could 
be restored if pH lowered to pH 2.0 and below (81) which explained presence of peptic activity 





Figure 1 pH activity and stability curves of pepsin 
 
Gastric acidity was thought to be the major limiting factor to HSA survival in the gut while little 
attention was paid to the influence of the gastric protease, pepsin on HSA activity. A study back 
in the early 1990’s revealed that pepsin resulted in more complete inhibition of salivary 
isoamylase than HCl alone (82). Given the pH dependence of pepsin, co-ingestion of kiwifruit 
(pH 3.0-3.5) may lower the pH of the gastric chyme, promoting early activation of pepsin which 
would contribute to further degradation of HSA in the stomach.  
 
2.6.1. Interaction of actinidin with pepsin  
 
The interaction between actinidin and pepsin in the stomach has not yet been studied, but as 
they are both proteases they could degrade one another with the outcome depending on pH. 
There have been anecdotal claims that kiwifruit is able to assist in gastric digestion. Given the 
wider pH range and specificity of actinidin than pepsin, actinidin was proposed to hydrolyse a 
broad range of proteins when pepsin activation was impaired at high pH, or open up protein 
structures for peptic activity contributing to a more rapid and complete digestion of proteins in 
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the stomach (83). However, this line of thought is challenged as the gastric acidity (~pH 2.0 and 
lower) is outside the optimum pH range of actinidin and the influence of pepsin on actinidin is 
less known.  
 
The role of kiwifruit containing actinidin in gastric digestion has been explored both in vitro (33, 
36) and in vivo (34, 35) in relation to protein digestion. Kaur et al (33) investigated the effect of 
actinidin extracts from green kiwifruit on gastric digestion of a range of proteins by simulating 
gastric digestion at pH 1.9 with pepsin for 30 min by assessing protein degradation on SDS-
PAGE. They found that the addition of actinidin enhanced digestibility of some relatively large 
proteins compared with pepsin alone, with digestion of α-, β-, k-caseins of sodium caseinate 
increased by 36%, 33% and 48%, respectively (33). However, a low pH of 1.9 might have 
impaired the catalytic activity of actinidin and solubility of some proteins leading to an 
underestimation, as digestive contents do not immediately encounter such a low pH in the 
stomach. A more profound effect of actinidin on protein breakdown was found by Donaldson et 
al who adopted an in vitro gastric model where freeze-dried beef was digested over a pH range 
of 1.3 to 6.2 by pepsin and actinidin of different concentrations for 60 min (36). Protein 
hydrolysis was increased by 27.5% with the addition of actinidin at a pH around 3.1 and this 
enhancing effect weakened as pepsin concentration increased. Despite the difference in 
enzyme concentrations between the two trials, the elevation of gastric pH from 1.9 to 3.1 
contributed to nearly twice the amount of increase (27.5% in Donaldson et al’s trial vs. 15% in 
Kaurl et al’s trial) in hydrolysis of beef muscle protein attributed to addition of actinidin. In vitro 
results indicated that actinidin enhanced gastric digestion of proteins especially when pepsin 
and acid secretions were insufficient.  
 
Kiwifruit actinidin was shown to increase gastric digestion and emptying of dietary proteins in pig 
(35) and rat (34) models by Montoya et al. Gastric chyme of growing rats fed 6 protein diets with 
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(freeze-dried green kiwifruit) and without (freeze-dried gold kiwifruit) actinidin treatment 
(equivalent to consuming 2 kiwifruit with an average-size meal for an adult) was obtained 60 min 
after gavage. Actinidin significantly increased the digestion of gluten by 3.2 fold and GE of beef 
muscle diets by 43% (p<0.05). These in vivo results were consistent with previous in vitro 
findings confirming that actinidin enhanced gastric digestion of some high-MW dietary proteins 
(MW>32 kDa). Although pH data were not available, higher physiological pH in the stomach 
could be accounted for by the enhanced effect of actinidin in digesting some protein. In addition, 
a significant negative correlation (p<0.05) between protein digestion and GE suggesting a 
possible role of kiwifruit actinidin in increasing the rate that dietary proteins are digested and 
emptied from the stomach for further degradation and absorption in the small intestine. Similar 
patterns were seen in growing pigs fed diets containing beef muscle and fresh kiwifruit pulp and 
assessed for protein breakdown in the gastric chyme over a 7 hour postprandial period (35). 
Significant increased digestion of beef muscle proteins (p<0.05), especially high-MW proteins 
(MW>34 kDa) was seen when actinidin was present either in the form of green kiwifruit pulp or 
gold kiwifruit supplemented with purified actinidin over 3 hours.  
 
Since kiwifruit actinidin was found to not only actively digest a broad range of proteins including 
HSA (32, 76) but also assisted digestion of high-MW proteins (MW>32 kDa) in the stomach 
when concentration and pH environment is not optimal for pepsin activity (33-36), it is rational to 
speculate that kiwifruit actinidin may degrade HSA (MW~56 kDa) rapidly before food enters the 






2.7. Buffering capacity 
 
Buffering capacity is the ability to resist a change in pH when acid or alkali is added. The 
buffering capacity of a food is mainly attributed to its composition such as organic acids and 
salts (84). A limited number of studies that have linked buffering capacity to organic acids in 
fruits have been related to alcoholic fermentation (85, 86) and dental erosion (87). Torjia et al 
(85) found that organic acids in grapes, tartaric and malic acids for example, were responsible 
for wine acidity and conferred different buffering capacity, which would prevent pH alterations in 
the process of fermentation. Li et al (86) investigated the effects of organic acids on buffering 
capacity of wort and observed a positive linear positive relationship between buffering capacity 
and level of organic acids. Among a range of organic acids, acetic acid and citric acid were 
found to contributed most substantially to the buffering capacity of wort (86).  
 
There has been little research on the effect of buffering capacity of organic acids on digestion 
and it has been limited to animal models (88, 89). The animal research found that feedstuffs 
with high buffering capacity led to pH remaining high in the stomach and proximal digestive 
track, impairing the activation of pepsin and breakdown of proteins in the stomach and leading 
to toxicity from excessive protein fermentation in the jejunum and colon (88). Incorporating 
organic acids was able to lower the acidity and buffering capacity of the feed, promoting peptic 
digestion of dietary proteins and inhibiting bacterial growth in the stomach (89). Mishra et al (31) 
proposed that sustained reduction in meal pH to 3.7 combined with a further delay in 
gastrointestinal pH adjustment to pH 2.0 due to the high buffering capacity of kiwifruit 
demonstrated in an in vitro titration analysis, could perhaps delay GE and partly accounted for 




2.8. Gastric emptying (GE)  
 
Incorporating organic acids in the processing and consumption of starchy foods has been 
adopted as a dietary approach to glycaemic control (40). The effects of vinegar dressing (29, 
90-97) and sourdough fermentation (28, 98-103) on postprandial glycaemia has been 
extensively studied in vitro, and in vivo with small sample sizes (n<16). A meta-analysis of 11 
cross-over clinical trials including 204 subjects in good health or with glucose metabolism 
disorders reported that acetic acid, administrated as vinegar contributed to a small but 
significant decrease in postprandial blood glucose and insulin responses (p<0.01). However, 
two of the trials claimed this effect was only significant when vinegar was consumed with high 
GI meals but not with low GI meals (93, 96). The underlying mechanisms have not yet been fully 
understood. Two of the possible factors were delayed GE (29, 104) and inhibited amylase 
activity by acidity discussed earlier (69, 92).  
 
A growing body of evidence has recognised the rate of transit of digesta from the stomach to the 
duodenum, that is, GE rate is a major determinant of postprandial glycaemic excursions in both 
healthy people (27, 105) and in those with diabetes (106, 107). Slowing GE is thought to 
decrease the rate that digestive contents enter the small intestine for predominant starch 
digestion and absorption and so reduce the postprandial glycaemic response and subsequent 
insulin demand. However, GE was found to determine the initial rise in blood glucose 
concentration as plasma glucose and insulin levels were positively related to GE at 30-60 min, 
but negatively related to GE at 120 min postprandially (27, 105, 107). This is due to a complex 
bidirectional relationship existing between GE and postprandial glycaemic response involving 
small intestinal inhibitory feedback, in which hypoglycaemia accelerates GE while 




There are many other factors besides acidity and buffering capacity conferred by the kiwifruit, 
including dietary fibre and various phytochemicals affecting gastric viscosity, particle breakdown 
and extent of digestion (65), that may all interact to affect the acidification and disintegration of 
digestive contents in the stomach and impose a delay on the rate of GE (40). Therefore, it is 
quite likely that kiwifruit could have a delaying effect, which would also retard glucose uptake 
from the small intestine and depress glycaemic response.  
 
Since HSA plays a significant role in the oro-gastric digestion of starch and the enzyme is 
susceptible to acid, citric acid inhibition and kiwifruit actinidin and pepsin degradation, a dietary 
approach targeting HSA inhibition has the potential to reduce glycaemic responses to starchy 
foods.  As a fruit carrying all factors mentioned above that contribute to HSA inhibition 
individually and interact collectively to delay GE, green kiwifruit may have the potential to reduce 
the rate of starch hydrolysis contributed by HSA during oro-gastro digestion and ultimately lower 
overall glycaemic response to co-ingested starchy foods. All above factors of kiwifruit should be 
reviewed and investigated thoroughly so that the mechanisms behind the glycaemic lowering 






3.1. Stage 1 Buffering capacity of fruits 
 
The aim of the Stage 1 experiments was to investigate the buffering capacity of various fruits 
during simulated gastric digestion both as individual fruits and when combined with a starchy 
food (Weet-Bix™ or oats). The buffering capacity was determined from the quantity of 
hydrochloric acid (HCl) of approximately physiological concentration required to reduce the pH 
of the gastric digestion medium to pH 2.0, and subsequently, the amount of sodium hydroxide 
(NaOH) required to raise the pH from 2.0 to 7.0. The addition of HCl (acid) and NaOH (base) 
was at approximately the in vivo rate, determined from literature values, so the titrations also 
gave an indication of the effect of buffering by fruit on the time taken for gastric acidification. 
 
3.1.1. Automated titration  
 
Stock solutions preparation 
Hydrochloric acid (HCl; 0.5 M) and sodium hydroxide (NaOH; 0.5 M) solutions were used as 
titrants for carrying out the acid-alkali titration. To prepare 0.5 M HCl, 49.1 ml of HCl stock 
(concentration: 32%, density: 1.16 g/L) was added to distilled (DI) water and made up to 1 L in a 
glass beaker. Calculations for working out the volume of HCl stock required are shown below: 
 
Moles of HCl in 1 L of solution = molarity (0.5 M) × volume of solution (1.0 L) = 0.5 mol 
Mass of HCl = moles of HCl (0.5 mol) × molar weight of HCl (36.46 g/mol) = 18.23 g 
Volume of HCl = mass of HCl (18.23 g) ÷ density of stock (1.16 g/ml) = 15.72 ml  
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Volume of stock solution = volume of HCl (15.72 ml) ÷ concentration of stock (32.0%) = 49.10 
ml 
 
To make 0.5 M NaOH, 20±0.01 g laboratory grade NaOH pellets were weighed on a calibrated 
weighing scale (Mettler Toledo, Columbus, OH, USA) and dissolved in DI water and made up to 
1 L in a glass beaker. Calculations for working out the weight of NaOH required are shown 
below:  
 
Moles of NaOH in 1 L of solution = molarity (0.5 M) × volume of solution (1 L) = 0.5 mol 
Weight of NaOH = moles of NaOH (0.5 mol) × molar weight of NaOH (40.0 g/mol) = 20.00 g 
 
Titrator setup 
A Metrohm 902 Titrando (Metrohm AG, Herisau, Switzerland) was used to perform automated 
acid-alkali titration under the control of supporting software Tiamo (Metrohm AG, Herisau, 
Switzerland). To mimic gastric digestion, acid/alkali dosing rate was set at a constant 2 ml/min, 
which was calculated based on literature data (gastric acid secretion rate 30 mEq/hr, 30 min for 
‘snack-type’ meal digestion) (60, 61). A semi-dynamic gastric digestion system was set up as 
shown in Figure 2. Digestion medium was constantly mixed at 37±2 °C  in a 1 L beaker by a 
heating magnetic stirrer (Thermo Fisher Scientific, Waltham, MA, USA) beneath and an 
overhead stirrer (Xin Rui Instruments, Jiangsu, China) simultaneously  operating at 10 rpm. 
Titration was performed using Set End-point Titration (SET) method with 2 endpoints (EP), pH 









Test foods preparation 
Fruits used in the titrations were fresh Pink Lady and Granny Smith apples (PAK’nSAVE), fresh 
Navel oranges (PAK’nSAVE), frozen black berries, strawberries, raspberries and blueberries 
(Woolworths), fresh Hayward kiwifruits (Zespri), frozen SunGold kiwifruits (Zespri), all in a 
ready-to-eat state of ripeness. Fresh fruits were stored at 4 ℃ until use, for no more than 2 
days. Frozen fruits were stored at -20 ℃ and thawed at 4℃ overnight. All fruits except berries 
were peeled, diced and blended into pulps. To fully release organic acids, diced apples were 
weighed before being stewed on medium-low heat for 10 min and then reweighed to determine 
moisture loss during cooking. The stewed apples were blended with enough DI water added to 
compensate for moisture lost in cooking.  Fruit pulps and artificial gastric salt solution (7 g/L 
gastric salt consisting of 50 g NaCl, 4 g CaCl2, 1 g NaHPO4 and 0.1 g MgCl2) were prepared 
and heated to 37℃ in a water bath (Grant Instruments, Cambridge, UK) beforehand. Weet-Bix™ 
Figure 2 Set up of a semi-dynamic gastric digestion system 
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(Sanitarium, 67 g CHO per 100 g) and rolled oats (Harraways, 56.2 g CHO per 100 g) were the 
starchy foods. The Weet-Bix™ biscuits consisted of lightly compressed whole wheat flakes and 
were easily crushed dry by hand to simulate chewing.  
 
3.1.2. Titration experiments 
 
To test and compare the buffering capacity of test foods, experiments consisted of titration of a 
water blank and two starchy foods controls, the individual fruit, and the individual fruit and a 
starchy food combined (Table 1) and were conducted in triplicate.  
 
Table 1 The compositions of test foods  








Water  - - 100 200 
Weet-Bix™ - 41.8  100 200 
Rolled oats  - 51.6  100 200 
Individual fruit 100  - - 200 
Fruit and Weet-Bix™ 100  41.8  - 200 
Fruit and rolled oats 100  51.6  - 200 
 
 
Test foods were mixed as shown in Table 1. Fruit pulps (100±0.01 g) were weighed into a 1L 
beaker, or in treatments not containing fruit DI water (100±0.01 ml) substituted for fruit pulp to 
keep a constant volume. Crushed Weet-Bix™ (41.8±0.01 g) or rolled oats (51.6±0.01 g), each 
containing 28 g available CHO were added in all except water blank and individual fruit 
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experiments.  Lastly gastric salt solution (200 ml), which was the least amount required to 
dissolve Weet-Bix™ biscuits and keep the pH electrode immersed, was added to all meals. The 
beaker was then moved onto the heating magnetic stirrer. Titration started once temperature 
reached 37 ℃, (within 5 min) and the pH reading had not changed for at least 5 seconds.  
 
Addition of starch significantly increased the viscosity of the digestion medium. Therefore, 
constant manual mixing was needed during acidification and early stage of neutralisation, 
especially in trials where Weet-Bix™ was used, because the dosing rate up to the set maximum 
rate was highly dependent on pH readings. Frequent checking of the pH electrode was also 
necessary as Weet-Bix™ and oats were likely to get clustered onto electrode probe. 
 
The following data were exported from Tiamo to Excel: (1) time (min); (2) pH; (3) HCl/NaOH 
volume dispensed (ml); (4) dosing rate (ml/min); (5) temperature (℃). The HCl/NaOH 
dispensing volume was multiplied by 0.5 to convert from ml to mEq as the molarity of titrant was 
0.5 M. The pH (y axis) and mEq of HCl/NaOH (x axis) were used to draw a titration curve for 
each test food. Data were plotted to compare the rate of acidification and neutralisation between 




3.2. Stage 2 Effect of pH on HSA activity  
 
The aim of Stage 2 experiments was to investigate the effect of pH on HSA activity over a pH 
range of 7.0 to 2.0. A buffer was developed so that the activity of HSA could be monitored at 
intervals of 1 pH unit.  
 
3.2.1. Buffer development 
 
A buffer solution was made by dissolving 0.5±0.01 g potassium hydroxide (KOH) and 1.0±0.01 
g citric acid in DI water to form 100 ml solution. It was named ‘kiwifruit buffer’ because it had 
similar amount of potassium (K) and citric acid as Zespri SunGold and ‘Hayward’ green kiwifruit 
(315 mg K and 900 mg citric acid per 100 g SunGold; 300 mg K and 970 mg citric acid per 100 
g Hayward). CaCl2 (100 ppm) was added to stabilize the HSA and reduce its inhibition by citric 
acid. The solution was then diluted 1:2 with water, as in titration 100 g kiwifruit pulp is diluted by 
approximately 200 ml of gastric salt solution. The final solution had a pH around 4.5 and was 
adjusted to pH 7.0 with 1 M KOH. This diluted CaCl2 fortified ‘kiwifruit buffer’ will be referred as 
‘Ca-KF buffer’ in the following context. To test the inhibition of HSA by citric acid in the buffer the 
activity of HSA in Ca-KF buffer titrated with 0.5 M HCl and NaOH was compared with its activity 







3.2.2. Starch digestion analysis 
 
The activity of HSA over a pH scale of 7.0 to 2.0 was measured by dissolving 2.5 ± 0.01 g pre-
gelatinised starch (BO11C, Davis Trading Company, Auckland, New Zealand) in 50 ml Ca-KF 
buffer, titrating the buffer from pH 7.0 to pH 2.0 with HCl (0.5 M), and measuring the activity of 
HSA  against the dissolved starch at each pH. During acidification, 1 ml of sample solution was 
taken out, in duplicate, at pH 7.0, 6.0, 5.0, 4.0, 3.0 and 2.0 into 10 ml test tubes. Fifty µl of fresh 
human saliva was added into each tube and mixed by pipetting. The saliva was the student’s 
own saliva collected after at least 6 hours of fasting. All tubes were incubated at 37±2 ℃ for 10 
minutes before adding 4 ml absolute ethanol to stop the digestion and precipitate undigested 
starch. The ethanolic samples were centrifuged (1000 rpm, 5 min, at room temperature) and 
stored at 4℃ before analysis of starch digestion products in the supernatant.  
 
Products of starch digestion (glucose, maltose and dextrins) in the ethanolic supernatants were 
measured as reducing sugars after a secondary digestion that converted the starch digestion 
products to free glucose.  For the secondary digestion, supernatant (50 µl) of each sample was 
incubated with 250 µl of “Enzyme solution A” for 15 min at room temperature. The Enzyme 
solution A consisted of 100 µl invertase (Megazyme E-INVERT, Megazyme, Bray, Co. Wicklow, 
Ireland) and 100 µl amyloglucosidase (Megazyme E-AMGDF, Megazyme, Bray, Co. Wicklow, 
Ireland) per 10 ml acetate buffer (pH 5.2), Free glucose was then measured as reducing sugar 
by the 3,5-Dinitrosalicylic acid (DNS) method (Figure 3). DNS solution was made by mixing 0.5 
mg/ml glucose, 4 M NaOH and DNS reagent (containing 10 g/L DNS, 16 g/L NaOH, 300 g/L 
potassium sodium tartrate) at a ratio of 1:1:5. For the reducing sugar analysis DNS solution (750 
µl) was added into each tube and the tubes were heated in boiling water for 15 min and cooled 
down in an ice bath before adding 4 ml of DI water to dilute. The absorbance was read at 530 
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nm using an auto-calibrated GENESYS 10S UV-Vis spectrophotometer (Thermo Fisher 
Scientific, Waltham, MA, USA). The absorbance data was entered into an Excel table to 
calculate mg of glucose released per g of starch as shown below.  
 
𝑚𝑔 𝑔𝑙𝑢𝑐𝑜𝑠𝑒 𝑖𝑛 𝑑𝑖𝑔𝑒𝑠𝑡𝑖𝑜𝑛 𝑚𝑒𝑑𝑖𝑢𝑚 =  10 × 50 × 5 ×
𝑂𝐷 (𝑠𝑎𝑚𝑝𝑙𝑒)−𝑂𝐷 (𝑏𝑙𝑎𝑛𝑘)








NB: Concentration of the glucose standard = 10 mg/ml; Volume of digestion medium= 50 ml; 
Correction factor = 0.9; Dilution factor = 5 
 
 Test Blank 
5 mg/ml glucose 
standard 
10 mg/ml glucose 
standard 
Sample 50 µl - - - 
DI water - 50 µl - - 
Glucose - - 50 µl 50 µl 
Enzyme A 250 µl 250 µl 250 µl 250 µl 
Mix well and incubate at room temperature for 15 min 
DNS reagent 750 µl 750 µl 750 µl 750 µl 
Mix well and incubate in boiling water for 15 min and then cool down in ice bath for 2 min 
DI water 4 ml 4 ml 4 ml 4 ml 
mix well and read absorbance at 530 nm against blank 
 
Figure 3 Process of DNS assay and compositions of reagents 
 
 
The amount of starch digested in 10 min by 50 µl of saliva in Ca-KF buffer and saline solution 
from pH 7.0 to 2.0 were compared in the same graph to illustrate the effect of pH and Ca-KF 
buffer on HSA activity. A student t-test was performed to test for any significant difference 
(p<0.01) between Ca-KF buffer and Ca-saline solution.   
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3.3. Stage 3 Effect of pepsin on HSA activity  
 
The aim of Stage 3 experiments was to investigate the effect of pepsin on HSA activity over a 
pH range of 7.0 to 2.0. The previous experiments suggested that use of pre-dissolved pre-
gelatinised starch solutions lead to pipetting errors due to the high viscosity of the starch 
solutions, producing errors in HSA analysis. Therefore, to improve accuracy a new approach to 
measuring HSA activity was adopted in which the pre-gelatinised starch was weighed into the 
analysis tube. 
 
3.3.1. Pepsin reaction 
 
Duplicate samples containing 5 ml of Ca-KF buffer were adjusted to pH 7.0, 6.0, 5.0, 4.0, 3.0 
and 2.0 using 0.5 M HCl and KOH. One ml of saliva and 100 µl of pre-made 10% (w/v) pepsin 
(Sigma P7125, Sigma-Aldrich, St. Louis, MO, USA) were added into each tube before 
incubation at 37±1  ℃ in a water bath for 30 min. To eliminate the effect of pH and only look at 
the effect of pepsin on HSA activity after exposure to pepsin, samples were then neutralised to 
pH 7.0 (HSA active, pepsin inactive) using 0.5 M KOH and then made up to 10 ml with DI water. 
Neutralisation started from samples at lower pH to higher pH so that the samples with the 
highest pepsin activity could be inactivated as soon as possible.  
 
3.3.2. Starch digestion analysis  
 
One ml of each neutralised sample was added into a test tube containing 50±0.01 mg of pre-
gelatinised starch. Digestion was initiated by incubating all tubes at 37±1 ℃. HSA activity was 
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determined by measuring the amount of starch digested at 0 min, 15 min and 30 min. Reaction 
was terminated by adding 4 ml of absolute ethanol at each time point. 0 min sample contained 1 
ml of buffer (pH 7.0) without saliva or pepsin. The same procedure as described for Stage 2 was 
conducted to measure absorbance of all samples using DNS assay and calculate mean mg/g 




3.4. Stage 4 Effect of kiwifruit actinidin on HSA activity  
 
The aim of the experiments in Stage 4 was to investigate the pH-dependence of the effect of 
kiwifruit actinidin on HSA activity. The protocol was developed step by step, with the following 
parameters set up and modified along the way: (1) concentration of kiwifruit sample; (2) pH of 
buffer; (3) control for fruit sugars; (4) pH adjustment method; (5) sampling method. 
 
3.4.1. Sample preparation 
 
Ready to eat green Hayward kiwifruit supplied by Zespri were skinned, blended into pulp and 
stored at -20 ℃. Frozen pulp was thawed and spun at 3000 rpm for 20 min at 4 ℃ to obtain 
actinidin extracts from the supernatant. Three different concentrations of kiwifruit samples 
(Table 2) were tested in duplicates. The control sample (0% kiwifruit, Table 2) contained only 
saliva and buffer.  
 
Table 2 Kiwifruit samples consisting of kiwifruit extracts and Ca-KF buffer at target pH 
Concentration of kiwifruit sample (%) 50% 10% 0% 
Volume of kiwifruit extracts (ml) 2.5 0.5 0 
Volume of pH adjusted Ca-KF buffer (ml) 2.5 4.5 5 
Total volume (ml) 5 5 5 
 
 
The experiment was carried out in duplicate. Pre-gelatinised maize starch (50±0.01 mg) was 
weighed into test tubes beforehand. The Ca-KF buffer was adjusted to pH 7.0, 6.0, 5.0, 4.0, 3.5, 
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3.0 and 2.0 using 0.5 M HCl and KOH and the Titrando titrator. A new pH point of 3.5 was of 
interest because 3.5 was found to be the initial pH of the digestion medium when kiwifruit was 
co-ingested with Weet-Bix™ or oats. At each pH, three concentrated samples were made by 
mixing kiwifruit extracts with buffer already adjusted to that pH (Table 2). Each sample was then 
immediately manually adjusted for pH again within 5 minutes due to the strong buffering 
capacity of kiwifruit.   
 
3.4.2. Kiwifruit actinidin reaction 
 
As soon as the pH was adjusted, 1 ml of saliva was added into the sample and incubated for 30 
min at 37±1 ℃ after mixing. At the end of 30 min, all samples were taken out of the water bath 
and neutralised to pH 7.0 using KOH and made up to a final volume of 10 ml to standardise 





Figure 4 Flow chart of the initial experiment protocol 
 
3.4.3. Starch digestion analysis  
 
As shown in Figure 4, 1 ml of each neutralised sample was taken to digest 50±0.01 mg pre-
gelatinised starch for 0, 15 and 30 min at 37±1 ℃. The sample solution was dispensed into the 
tube at an angle and at a speed which would quickly disperse and dissolve the starch to form a 
uniform solution. A clean Pasteur pipet was used as a stirring rod to aid dissolving if a lump was 
seen. Kiwifruit extracts contained fruit sugars that were included in total reducing sugars by 
DNS method. Therefore, another 1 ml was taken from all samples except control (0% kiwifruit) 
Make 5 ml of 50%, 10% and 0% kiwifruit sample at different target pH  
Measure pH of each kiwifruit sample and adjust back to its original target pH  
 
Add 1 ml saliva into each sample, mix well and incubate for 30 min at 37 °C 
Neutralise all samples to pH 7.0 and add DI water to make up to 10 ml 
Take 1 ml of each sample into a blank test tube and a test tube containing 50 mg of pre-gelatinised starch, 
incubate at 37 °C for 15 and 30 min  
At each time point, add 4 ml of absolute ethanol to each tube and spin at 1000 rpm for 5 min  
Take 50 µl of supernatant for DNS analysis 
36 
 
into a blank test tube to determine kiwifruit sugars in the sample. The amount of fruit sugars was 
then subtracted from the total reducing sugars to determine the amount of starch digested by 
HSA in each sample. Starch digestion at time 0, 15 and 30 min was plotted to reflect the effect 
that kiwifruit actinidin had had on HSA activity due to exposure to kiwifruit at different pH levels. 
A student t-test was performed to test for any significant difference (p<0.01).  
 
3.4.4. Further modifications  
 
A few more modifications were made regarding kiwifruit concentrations, pH adjustment, and 
sampling method. The final protocol for this part is shown in Figure 5 with modifications 
highlighted in bold. Firstly, 0% and 50% were selected to be the two concentrations to be tested. 
Secondly, 5 ml of kiwifruit extracts was adjusted to each target pH before mixing with pH-
adjusted buffer to make up a 10 ml 50% kiwifruit sample. No further pH adjustment was needed. 
2-Mercaptoethanol (0.2%) was added into extracts as an antioxidant to stabilise actinidin during 
pH adjustment and incubation. In addition, the experiment scale was increased with the ratio 
between reagents kept the same so that 15 and 30 min samples could be taken from the 
sample tube during starch digestion analysis. Furthermore, SunGold kiwifruit and Granny Smith 





Figure 5 Flow chart of the modified experiment protocol with modifications in bold  
Pipette 5 ml kiwifruit extracts and adjust to target pH with 1 M KOH 
Add Ca-KF buffer (already adjusted to target pH) to make 10 ml sample 
Add 2 ml saliva into each sample, mix well and incubate for 30 min at 37 °C 
Use KOH to neutralize all samples to pH 7.0 and add DI water to make up to 20 ml 
Pipette 5 ml of each sample into a blank test tube (for fruit sugar measurement) and a test tube 
containing 250 mg of pregelatinised starch, incubate at 37 °C 
At 15 and 30 min time point, pipette 1 ml sample into test tube containing 4 ml of absolute ethanol and mix 
thoroughly 
Spin at 1000 rpm for 5 min  
Take 50 µl of supernatant sample solution for DNS analysis 
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3.5. Stage 5 Effect of kiwifruit actinidin-pepsin interaction on HSA activity 
 
The aim of Stage 5 experiments was to investigate how the interaction between pepsin and 
kiwifruit actinidin affected their joint effect on HSA activity at pH 4.0, 3.5, 3.0 and 2.0. This pH 
range was selected because Stage 1 results suggested co-ingestion of kiwifruit would lower the 
pH of a food bolus to around pH 3.5-4.0 due to the acidity and buffering capacity of kiwifruit.  
 
3.5.1. Gastric digestion and starch digestion analysis  
 
A similar digestion procedure was followed as in Stage 4 (Figure 4) except that 0.24 ml of 10% 
(w/v) pepsin (Sigma P7125, Sigma-Aldrich, St. Louis, MO, USA) was added along with saliva 
(Figure 6). In addition, an extra tube containing the same reagents except kiwifruit extracts was 





Figure 6 Flow chart of the experiment protocol with new procedures in bold 
 
Starch digestion analysis was used to determine the amount of starch digested by HSA 
remaining in each tube, to reveal how HSA activity was affected by the interaction between 
actinidin and pepsin at pH 4.0, 3.5, 3.0 and 2.0 during 30 min digestion. A one millilitre sample 
was also removed from the digestion medium for gel-electrophoresis, and immediately stored at 
-80 °C until analysis. 
  
Pipette 5 ml kiwifruit extracts and adjust to target pH with 1 M KOH 
Add Ca-KF buffer (already adjusted to target pH) to make 10 ml sample 
Add 2 ml saliva followed by 240 µl 10% pepsin into each sample, mix and incubate for 30 min at 37 °C 
Use KOH to neutralize all samples to pH 7.0 and add DI water to make up to 20 ml 
Pipette 5 ml of each sample into a blank test tube (for fruit sugar measurement) and a test tube containing 
250 mg of pregelatinised starch, incubate at 37 °C 
Pipette 1 ml from each sample into an Eppendorf tube and stored at -80°C 
 
At 15 and 30 min time point, pipette1 ml sample into 4 ml of absolute ethanol and mix thoroughly 
Spin at 1000 rpm for 5 min  
Take 50 µl of supernatant sample solution for DNS analysis 
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3.5.2. Sodium Dodecyl Sulphate-Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
 
Gastric digestion samples stored at -80 ℃ were used for protein analysis in duplicate on step 
gradient polyacrylamide gels (10%, 15% and 20% acrylamide) using a Bio-Rad Mini-Protean® II 
electrophoresis system (Bio-Rad Laboratories, Hercules, CA, USA) following the method of 
Laemmli (109). Step-gradient polyacrylamide gels were cast in pre-made gel chambers before 
well-forming combs were inserted (Table 3 shows the gel composition). After polymerisation the 
combs were removed and the wells were filled with SDS/Tris/Glycine running buffer. 
 
Table 3 The compositions of 10%, 15% and 20% acrylamide gels and stacking gel 
 10% 15% 20% Stacking 
H2O 1.7 ml 1 ml 0.3 ml 2.25 ml 
Acrylamide/Bis-acrylamide, 30% solution 1 ml 2 ml 2.7 ml 0.68 ml 
1.5 M Tris pH 8.8 1 ml 1 ml 1 ml - 
0.5 M Tris pH 6.8 - - - 1 ml 
10% SDS 40 µl 40 µl 40 µl 40 µl 
2,2,2-Trichloroethanol 20 µl 20 µl 20 µl - 
10% Ammonium persulfate  20 µl 20 µl 20 µl 20 µl 
N,N,N’,N’- Tetramethylethylenediamine  4 µl 4 µl 4 µl 4 µl 
 
 
Thawed samples were made to the same concentration with sample loading buffer (Table 4) 
and treated with E64 (Sigma E3132, Sigma-Aldrich, St. Louis, MO, USA) and Pepstatin A 
(Sigma P5318, Sigma-Aldrich, St. Louis, MO, USA) which are two selective inhibitors of 
actinidin and pepsin, respectively. Samples were then boiled at 95 ℃ for 5 min and centrifuged 
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at 14,680 rpm for 1 min before being loaded onto the gels along with a molecular weight marker. 
Electrophoresis was performed at 0.05A for approximately 70 min at room temperature. Protein 
bands in the gels were visualised with Trichloroethanol (ReagentPlus®, ≥99%, Sigma T54801, 
Sigma-Aldrich, St. Louis, MO, USA) which allows fluorescent detection of tryptophan-containing 
proteins without staining. The gels were scanned under ultraviolet light by the Gel Doc XR+ 
Imager (Bio-Rad Laboratories, Hercules, CA, USA) and the protein bands were analysed by 
Quantity One® 1-D analysis software (Bio-Rad Laboratories, Hercules, CA, USA).  
 
Table 4 The compositions of sample loading buffer (2X loading buffer for 10 ml) 
 ml (for 10 ml) Concentration  
0.5 M Tris pH 6.8 2 ml 0.1 M 
Glycerol 2.5 ml 25% 
10% SDS 4 ml 4% 
H2O 1.5 ml / 
Bromophenol blue  2 mg 0.02% 
2-Mercaptoethanol 0.4 ml 4% 
 
 
3.5.3. Actinidin kinetic assay  
 
The same batch of frozen gastric digestion samples as used for gel electrophoresis were used 
for kinetic analysis of actinidin, in duplicate, on white 384-shallow well microplates (ProxiPlate-
384 Plus, PerkinElmer, Waltham, MA, USA) in 20 µl volumes. Thawed samples were put 
through a series of gradient dilutions using 0.1 M sodium acetate buffer pH 4.5 containing 0.2% 
2-Mercaptoethanol and 0.2% Igepal. Kiwifruit was homogenised in a glass Dounce hand-held 
42 
 
homogeniser and assayed at a final dilution of x20 in the microplate. Actinidin activity was 
determined from coumarin fluorescence read at excitation and emission wavelengths of 351 and 
430 nm (bandwidth 20 nm) by a Tecan Spark® 20 M multimode microplate reader (Tecan 
Group, Männedorf, Switzerland) controlled by SparkControl software immediately after addition 
of the coumarin-yielding substrate Z-Phe-Arg-7-amido-4-methylcoumarin Hydrochloride (Sigma 
C9521, Sigma-Aldrich, St. Louis, MO, USA) at a final concentration of 200 µM. Data were 
plotted in Excel with fitted curves to compare actinidin activity at pH 4.0, 3.5, 3.0 and 2.0 during 
30 min of interaction with pepsin and HSA.  
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3.6. Stage 6 Meal study 
 
The aim of the Stage 6 experiments was to investigate the effect of green kiwifruit pulps on HSA 
activity co-ingested with Weet-Bix™ during simulated gastric acidification.  
 
3.6.1. Saliva secretion  
 
To get an estimation of how much saliva is secreted in chewing of 41.8±0.01 g Weet-Bix™ until 
ready to be swallowed, hand-crushed dry biscuits were chewed by the student and 
expectorated into a re-sealable plastic bag at onset of the urge to swallow. The wet boluses 
were mixed by massaging the sealed bag. Four sub-samples were taken and weighed 
individually (recorded as 𝑊𝑦)  immediately before transferred to a vacuum oven (Lab-Line 
Instruments, Inc., Melrose Park, IL, USA) for drying at 100 °C overnight under vacuum. Each 
dried sub-sample was reweighed (weight recorded as 𝑊𝑥). Calculations for working out the 
theoretical amount of saliva to add to 41.8 g of Weet-Bix™ in the whole bolus were carried out 
as follows: 
 
Saliva as a % of dry weight (S) = (𝑊𝑦 - 𝑊𝑥) × 100 / 𝑊𝑦  % 
Therefore, weight of saliva required for 41.8 g of Weet Bix is S/100 × 41.8 g  
 
As this was an estimation, the moisture content of the dry Weet-Bix™ and the dry matter 





3.6.2. Gastric digestion  
 
To investigate the effect of pepsin-actinidin interaction on HSA activity during simulated gastric 
digestion of Hayward kiwifruit and Weet-Bix™ combined, experiments consisted of titration of a 
Weet-Bix™ control and three treatments (Kiwifruit, pepsin, Kiwifruit + pepsin; Table 5) were 
conducted in duplicate.  
 
Table 5 Compositions of test foods  
Test product Enzyme Starch 
Weet-Bix™ (control) 28 ml saliva1 
(100 g water) 
41.8 g Weet-Bix™ 
Actinidin  28 ml saliva  
100 g Hayward pulp  
41.8 g Weet-Bix™ 
Pepsin 28 ml saliva 
(100 g water) 
7 ml 10% pepsin2 
41.8 g Weet-Bix™ 
Actinidin & pepsin 28 ml saliva  
100 g Hayward pulp  
7 ml 10% pepsin 
41.8 g Weet-Bix™ 
 
 
                                                 
1 28 ml saliva was calculated according to data obtained from saliva secretion experiment which 
found saliva secreted to chew Weet-Bix™ was 66% of the dry weight of Weet-Bix™ biscuits so 
theoretically 28 ml saliva would be secreted to chew 41.8 g Weet-Bix™. 
2 Previously gastric digestion study (unpublished) used 1 ml 10% pepsin in 50 ml digestion 
medium so 7 ml of the same pepsin was used in 340 ml digestion medium. 
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The compositions of control and treatments were shown in Table 5 and the experiment protocol 
was shown in Figure 6. Thawed green kiwifruit pulp, fresh saliva, 7 g/L gastric salt solution, 
10% w/v pepsin were pre-warmed to 37 °C in a water bath beforehand. Crushed Weet-Bix™ 
(41.8±0.01 g) were weighed into a 1 L beaker and mixed with 100±0.01 g of kiwifruit pulps for 
30 seconds. Pre-warmed saliva (28 ml, based on preliminary data on saliva secretion) was 
added and mixed for 1 min using a spatula before adding 7 ml of 10% pepsin and 200 ml of 
gastric salt solution. The above procedure was completed in 4 min. The first sample was taken 
at 5 min and added into a tube containing 4 ml of absolute ethanol. Samples were taken at each 
0.5 pH unit. Due to high viscosity of the sample, pipette tips were cut to prevent blocking. Tips 
were inserted into ethanol for dispensing and ejected into the tube for mixing. The mixture was 
poured into a 500 ml measuring cylinder to measure final volume after completion. Volume of 
digesta for each sample was calculated from the final volume and amount of acid dispensed at 
each sampling as recorded by the titrator’s program Tiamo. The calculated volumes were used 
for calculating starch digestion in Excel from results of DNS analysis of digestion products as 
before. Data were plotted to compare between Weet-Bix™ control and three treatments, to 






Figure 7 Flow chart of the experiment protocol  
Mix 28 ml saliva with test foods for 1 min  
Add 200 ml gastric salt solution 
Take 1 ml of baseline sample immediately 
At 5 min start titration and take 1 ml sample at every 0.5 pH unit into 4 ml ethanol and mix well  
Pipette 5 ml of each sample into a blank test tube (for fruit sugar measurement) and a test tube containing 
250 mg of pregelatinised starch, incubate at 37 °C 
At 15 and 30 min time point, pipette1 ml sample into 4 ml of absolute ethanol and mix thoroughly 
Spin at 1000 rpm for 5 min  
Take 50 µl of supernatant sample solution for DNS analysis 
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4. Results  
 
4.1. Buffering capacity of fruits  
 
The buffering capacity of test foods measured as mEq of 0.5 M HCl required to titrate from their 
initial pH down to gastric pH 2.0, and in the amount of 0.5 M NaOH consumed to titrating back 
towards intestinal pH 7.0 is shown in Table 6. Addition of 200 ml of gastric salt solution did not 
alter the pH of test foods. Titration of water blank showed that the gastric salt solution had no 
buffering effect. All of the fruits tested were able to substantially reduce the pH of the gastric 
medium from near neutral to within a pH range of 2.9-3.6. However, despite the similarity of the 
initial pH of the gastric media immediately after adding the fruit, titration revealed that they 
differed considerably in buffering capacity. The test food with the greatest buffering capacity 
was SunGold kiwifruit that consumed an average of 13.4 mEq HCl compared with 4.66 mEq 













Table 6 Acid (0.5 M HCl) and alkali (0.5 M NaOH) required (mean±SD) to titrate test foods1 
from their initial pH down to pH 2.0 and subsequently up to pH 7.0 at room temperature 
Test foods Initial pH Acid (mEq) Alkali (mEq) 
Water blank 7.7 2.8±0.3 3.1±0.3 
Pink lady apple 3.2 4.7±0.1 11.5±0.2 
Blueberry 3.0 5.4±1.1 16.7±1.4 
Granny smith apple 3.3 5.8±0.3 14.5±0.8 
Strawberry 3.4 6.8±0.1 15.8±0.5 
Raspberry 2.9 6.9±0.0 31.7±0.2 
Blackberry 3.3 8.8±0.1 21.6±0.2 
Hayward kiwifruit 3.3 10.5±0.8 30.8±0.3 
Orange 3.6 11.0±0.2 21.7±0.5 
SunGold kiwifruit 3.4 13.4±0.2 35.0±1.0 
 
 
The buffering capacity of a control and three fruits (Granny smith apple, Hayward and SunGold 






                                                 
1 Test foods consisted of 100 g fruit pulp and 200 ml gastric salt solution, while water blank had 
100 g water substituted for fruit. Titration was performed at a constant dosing rate with acid and 
alkali dispensed at 2 ml/min. 
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Table 7 Acid (0.5 M HCl) and alkali (0.5 M NaOH) (mean±SD) and mean time required (min) 
required to titrate test foods1 from their initial pH down to pH 2.0 and subsequently up to pH 7.0 














Weet-Bix™ control - 5.5 11.4±0.1 12 13.8±0.0 14 
Granny smith apple + Weet-Bix™ 3.3 4.0 12.5±0.7 14 24.6±0.9 26 
Hayward kiwifruit + Weet-Bix™ 3.3 3.6 17.7±2.5 20 43.2±1.6 45 
SunGold kiwifruit + Weet-Bix™ 3.4 3.7 22.3±0.2 23 46.5±0.6 48 
 
 
The titration curves of the control and the three fruits (Granny smith apple, Hayward and 
SunGold kiwifruits) when co-ingested with Weet-Bix™ in a simulated gastric acidification and a 
subsequent intestinal neutralization is shown in Figure 8.  
 
                                                 
1 Test foods consist of 41.8 g crushed Weet-Bix™, 100 g fruit pulp and 200 ml gastric salt solution, 
while control had 100 g water substituted for fruit. Titration was performed at a constant dosing rate 




Figure 8 Mean acid and alkali (mEq) required to titrate Weet-Bix™ control (W), Granny smith 
apple + Weet-Bix™ (A+W), Hayward kiwifruit + Weet-Bix™ (H+W) and SunGold kiwifruit + 
Weet-Bix™ (S+W) down to pH 2.0 and subsequently up to pH 7.0 at room temperature 
 
 
The buffering capacity of a control and three fruits (Granny smith apple, Hayward and SunGold 























Table 8  Acid (0.5 M HCl) and alkali (0.5 M NaOH) (mean±SD) and mean time required (min) to 
titrate test foods1 from their initial pH down to pH 2.0 and subsequently up to pH 7.0 at room 
temperature. 












Oats control - 5.8 15.4±0.1 18 15.9±0.3 17 
Granny smith apple + oats 3.3 4.0 17.4±0.1 18 29.0±0.3 31 
Hayward kiwifruit + oats 3.3 3.5 23.6±0.2 25 47.1±0.5 49 
SunGold kiwifruit + oats 3.4 3.8 24.3±0.1 26 47.3±0.4 49 
 
 
The titration curves of the control and the three fruits (Granny smith apple, Hayward and 
SunGold kiwifruits) when co-ingested with rolled oats in a simulated gastric acidification followed 
by a subsequent intestinal neutralization is shown in Figure 9.  
 
 
                                                 
1 Test foods consist of 51.6 g rolled oats, 100 g fruit pulp and 200 ml gastric salt solution, while 
control had 100 g water substituted for fruit. Titration was performed at a constant dosing rate with 




Figure 9 Mean acid and alkali (mEq) required to titrate oats control (O), Granny smith apple + 
oats (A+O), Hayward kiwifruit + oats (H+O) and SunGold kiwifruit + oats (S+O) down to pH 2.0 
and subsequently up to pH 7.0 at room temperature 
 
 
The buffering capacity of the fruits is clearly to be seen in the titration curves of the fruit-cereal 
combinations (Figures 8 and 9). Although the fruit-cereal combinations were similar in initial pH 
the acid consumed in acidification to pH 2.0 was almost twice as much for the kiwifruit-cereal 
combination as for the cereal alone. Addition of each of the three fruits reduced the pH while 
increased the buffering capacity in combination with both cereal foods in the order of SunGold> 
















4.2. Effect of pH and Ca-KF buffer on HSA  
 
The activity of HSA in Ca-KF buffer that was developed for the experiments against Ca-saline 
solution at a pH range of 7.0 to 2.0 was studied by measuring mg/g starch digested in 10 
minutes at 37°C (Table 9). Starch digestion by saliva in Ca-saline solution and Ca-KF buffer 
was significantly different at pH 3.0 to 6.0 (p<0.001).  
 
 
Table 9 Starch digested (mean±SD) in 10 minutes in by 50 µl of saliva in Ca-saline solution and 
Ca-KF buffer at a pH range of 7.0 to 2.0 at 37°C 
pH 
Starch digested (mg/g)  
Ca-saline solution Ca-KF buffer P value 
7.0 366.4±89.7 318.8± 56.0 0.203 
6.0 373.2±75.3 264.2± 60.3 p<0.001 
5.0 309.2± 38.7 152.6± 53.5 p<0.001 
4.0 201.9± 27.5 19.6± 10.0 p<0.001 
3.0 43.8± 13.5 15.2± 8.8 p<0.001 
2.0 19.3± 5.3 15.9± 8.3 0.154 
 
 
A scatterplot of starch digestion in 10 minutes by 50 µl saliva in Ca-saline solution and Ca-KF 
buffer a pH range of 7.0 to 2.0 is shown in Figure 10. HSA in saliva used for this experiment 
exhibited maximal activity at pH 7.0 and minimal activity at pH 2.0 and a decreasing trend in 
starch digestion as pH decreased was observed in both solutions. Little starch was digested by 
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HSA in Ca-KF buffer at pH 4.0 and 3.0 compared to a significantly larger amount digested in 
Ca-saline buffer.  
 
 
Figure 10 Mean starch digested (mg/g) in 10 minutes in by 50 µl of saliva in Ca-saline solution 
and Ca-KF buffer at a pH range of 7.0 to 2.0 at 37°C 
 
 
Given the little starch digestion by 50 µl saliva in 10 min in Ca-KF buffer at low pH, the maximal 
activity of HSA in a larger amount of saliva (50 µl and 100 µl) over a longer period of time (0-60 



































Ca-saline solution Ca-KF buffer
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Table 10 Starch digested (mean±SD) over 60 minutes by 50 µl and 100 µl fresh saliva in 
neutralized Ca-KF buffer (pH 7.0) at 37°C 
Time (min) 
Starch digested (mg/g) 
50 µl saliva 100 µl saliva 
0 6.7±0.9 21.9±2.7 
5 136.7±24.1 216.9±19.0 
10 189.4±23.6 313.4±27.8 
20 377.3±50.2 425.4±22.4 









A scatterplot of starch digestion by HSA in 50 and 100 µl of saliva at its optimal pH 7.0 over 60 
minutes is shown in Figure 11. Although 100 µl saliva digested more starch than 50 µl saliva, a 





Figure 11 Mean starch digested (mg/g) over 60 minutes by 50 µl and 100 µl fresh saliva in 
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4.3. Effect of pepsin on HSA 
 
Given the pH sensitivity of HSA to pH treatments, all samples were neutralized before 
conducting starch digestion analysis to eliminate the effect of pH on HSA activity from this part 
onwards. In addition, one ml of saliva would be used as starch digestion by 50 µl and 100 µl of 
saliva might not be sufficient for investigating effects of additional treatments on HSA activity. 
 
The activity of HSA under the effect of pepsin at different pH was investigated by measuring 
mg/g starch digested by remaining HSA at pH 7.0 after 30 minutes of pre-incubation with 10% 
pepsin at a pH range of 7.0 to 2.0 (Table 11). 
 
 
Table 11 Starch digested (mean±SD) in 15 and 30 minutes by saliva after 30 minutes pre-
incubation with 10% pepsin in Ca-KF buffer at a pH range of 7.0 to 2.0 at 37°C 
pH before neutralization 
Starch digested (mg/g) 
15 min starch digestion 30 min starch digestion 
7.0 611.5±72.2 681.7±106.4 
6.0 624.1±99.1 583.3±110.8 
5.0 575.3±89.8 634.1±83.7 
4.0 355.5±40.5 507.6±73.0 
3.0 328.6±161.6 485.7±151.1 





A scatterplot of remaining HSA activity after pepsin treatment as measured by starch digestion 
in 15 and 30 minutes is shown in Figure 12. HSA appeared to be able to resist 30 minutes of 
pre-incubation with 10% pepsin at about pH 5.0 and above but activity declined as pH dropped 
below 4.0. No HSA activity was found at pH 2.0. 
 
 
Figure 12 Mean starch digested (mg/g) in 15 and 30 minutes by saliva after 30 minutes pre-
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4.4. Effect of fruits on HSA 
 
4.4.1. Hayward kiwifruit  
 
The effect of 30 min Hayward kiwifruit treatment at different pH on HSA activity as measured by 
mg/g starch digested by remaining HSA is shown in Figure 13. Hayward kiwifruit treatment at 
pH 4.0 resulted in a drop in HSA activity. 
 
Figure 13 Mean starch digested (mg/g)1  in 15 and 30 minutes by saliva after 30 minutes pre-
incubation with in Ca-KF buffer at a pH range of 7.0 to 2.0 at 37°C with 50% Hayward kiwifruit 
and without kiwifruit (control) 
 
 
                                                 
1 A background reading of 20.3 mg/g (blank containing 50 mg pre-gelatinized starch in pH 7.0 
























Hayward 15min control 15min Hayward 30min control 30min
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A student t-test was conducted to test the significance of difference between starch digestion by 
remaining HSA in saliva controls and Hayward treated samples and the p values are reported in 
Table 12. Pre-incubation with Hayward kiwifruit inhibited HSA activity as shown by a significant 
reduction (p<0.01) in both 15 and 30 minutes of starch digestion in the Hayward treated sample 
compared with controls at pH 4.0 and below.  
 
 
Table 12 p values of a student t-test for Hayward treatment 
 p value of t-test (Hayward treatment vs. control) 
 pH 2.0 pH 3.0 pH 3.5 pH 4.0 pH 5.0 pH 6.0 pH 7.0 
15 min starch 
digestion 
p<0.001 p<0.001 p<0.001 p<0.001 0.007 0.264 0.037 
30 min starch 
digestion 
p<0.001 p<0.001 p<0.001 p<0.001 0.013 0.003 0.003 
 
 
4.4.2. SunGold kiwifruit 
 
Pre-incubation with SunGold kiwifruit at pH 3.5 and below led to inhibited HSA activity as shown 
in Figure 14. The data point at pH 3.5 for control at 30 min may have included an outlier as 
indicated by the acute deviation in the graph and large SD. There was little HSA activity 
remained in SunGold samples treated at pH 3.0. In contrast to the Hayward kiwifruit the 





Figure 14 Mean starch digested (mg/g)1 in 15 and 30 minutes by saliva after 30 minutes pre-
incubation with 50% SunGold kiwifruit in Ca-KF buffer at a pH range of 7.0 to 2.0 at 37°C 
 
 
P values of a student t-test are reported in Table 13. Pre-incubation with SunGold kiwifruit 
inhibited HSA activity as shown by a significant reduction (p<0.01) in both 15 and 30 minutes of 
starch digestion in the SunGold treated sample compared with controls at pH 3.0. 
 
 
Table 13 p values of a student t-test for SunGold treatment 
 p value of t-test (SunGold treatment vs. control) 
 pH 2.0 pH 3.0 pH 3.5 pH 4.0 pH 5.0 pH 6.0 pH 7.0 
15 min starch 
digestion 
0.002 p<0.001 0.027 0.380 0.066 0.674 0.147 
30 min starch 
digestion 
p<0.001 p<0.001 0.046 0.169 0.238 0.379 0.035 
                                                 
1 A background reading of 12.7 mg/g (blank containing 50 mg pre-gelatinized starch in pH 7.0 
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4.4.3. Granny Smith apple  
 
Figure 15 shows the starch digestion by remaining saliva in controls and Granny Smith apple 
treated samples pre-incubated at a pH range of 7.0 to 2.0. HSA activity were consistent 
throughout the pH range in both control and Granny Smith apple treated samples.  
 
Figure 15 Mean starch digested (mg/g)1 in 15 and 30 minutes by saliva after 30 minutes pre-
incubation with 50% granny smith apple in Ca-KF buffer at a pH range of 7.0 to 2.0 at 37°C 
  
 
A student t-test (p values reported in Table 14) revealed a significant but small difference 




                                                 
1 A background reading of 14.9 mg/g (blank containing 50 mg pre-gelatinised starch in pH 7.0 
























Granny Smith 15min control 15min
Granny Smith 30min control 30min
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Table 14 p values of a student t-test for Granny Smith apple treatment 
 p value of t-test (apple treatment vs. control) 
 pH 2.0 pH 3.0 pH 3.5 pH 4.0 pH 5.0 pH 6.0 pH 7.0 
15 min starch 
digestion 
0.124 0.007 0.196 0.974 0.748 0.157 0.063 
30 min starch 
digestion 





4.5. Effect of pepsin and kiwifruit actinidin on HSA 
 
4.5.1. Starch digestion  
 
The effect of pepsin alone and pepsin combined with Hayward kiwifruit on HSA activity at pH 
4.0 to 2.0 is presented in Figure 16. Pre-incubation with pepsin alone at pH 3.0 and 2.0 
completely inactivated HSA activity as no starch digestion was seen at those low pH levels. 
Treatment with pepsin and Hayward kiwifruit combined lowered the HSA activity at pH 4.0 and 
3.5, but more HSA activity survived at pH 3.0 compared to treatment with pepsin alone.  
 
 
Figure 16 Mean starch digested (mg/g)1 in 15 and 30 minutes by saliva after 30 minutes pre-
incubation with 10% pepsin and 50% Hayward kiwifruit in Ca-KF buffer at a pH range of 4.0 to 
2.0 at 37°C compared with incubation with 10% pepsin alone 
                                                 
1 A background reading of 15.5 mg/g (blank containing 50 mg pre-gelatinised starch in pH 7.0 
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SDS-PAGE analysis of pre-incubated samples (A) 1 and samples from a small scale experiment 
following the same protocol (B, C, D) 2 are presented in Figure 17. Both experiments produced 
similar results although the concentrations of pepsin and kiwifruit differed between them. HSA, 
pepsin and actinidin appeared on SDS as bands at approximately 56, 40 and 28 kDa, 
respectively. Pepsin actively degraded actinidin as well as HSA with and without the presence 
of actinidin at pH 2.0 and 3.0. Pepsin activity declined as the pH increased above 3.5. Actinidin 





                                                 
1 Experiment A used 10% pepsin (>400 U/mg protein) and 50% kiwifruit. 
2 Experiment was a small scale experiment conducted in Eppendorf tubes following the same 




Figure 17 SDS-PAGE of HSA digested with pepsin and kiwifruit actinidin. (A) Neutralized pre-
incubated samples (30 min, 37°C) in which saliva was treated with pepsin alone and pepsin + 
Hayward kiwifruit at pH 2.0, 3.0, 3.5 and 4.0. (B) The control sample contained HSA, inhibited 
pepsin (with its selective inhibitor pepstatin) and inhibited actinidin (with its selective inhibitor E-
64). In the test samples, saliva was treated with pepsin + Hayward kiwifruit with inhibited 
actinidin; (C) The saliva samples contained pepsin + Hayward kiwifruit with active actinidin; (D) 
The saliva samples contained inhibited pepsin (with its selective inhibitor pepstatin) + Hayward 




4.5.3. Actinidin activity 
 
The kinetic activity of actinidin that remained in the samples after pre-incubation with pepsin is 
presented in Figure 18. The sample pre-incubated at pH 4.0 exerted the highest actinidin 




Figure 18 The kinetic activity of remaining actinidin after pre-incubation at pH 2.0, 3.0, 3.5 and 
4.0 followed by neutralization was determined from coumarin fluorescence read at excitation 
and emission wavelengths of 351 and 430 nm. Samples were subjected to gradient dilutions 




4.6. Effect of pepsin and kiwifruit actinidin on HSA in Weet-Bix™ meal 
 
4.6.1. Saliva secretion 
 
Approximately 28 g (28 ml) of saliva is required for chewing 41.8 g Weet-Bix™ according to an 
average of 66.1% saliva secretion of dry Weet-Bix™ (Table 15). This estimation will be used in 
the following experiment to mimic the oral and gastric phase of starch digestion.  
 
Table 15 Estimation of saliva secretion determined from weight difference between chewed 
Weet-Bix™ (wet bolus) and freeze-dried bolus samples produced in a chewing test. 
 Sample 1 Sample 2 Sample 3 Sample 4 
Weight of wet bolus (g) 4.7 5.6 4.9 5.4 
Weight of dried bolus (g) 2.8 3.4 3.0 3.2 
Weight of saliva (g)1 1.9 2.2 1.9 2.2 




4.6.2. Starch digestion 
 
Samples in this part of the experiment were not neutralized after pre-incubation. The amount of 
starch digested (mg/g) (including fruit sugars where applicable) during gastric acidification in 
                                                 
1 Difference between wet and dried bolus was assumed to be loss of saliva. The moisture 
content of the dry Weet-Bix™ and the dry matter content of saliva were not accounted for.  
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each test food1 is presented in Figure 19. Granny Smith apple is compared with the other fruit 
treatments at the same sample pH although its digestion time was the shortest due to low 
buffering capacity. Starch digestion was consistent as pH decreased from 5.0 to 2.0 in both 
control and pepsin treated samples (Figure 19 A), while fruit treated samples started at a low 
pH resulting in low starch digestion (Figure 19 B).  
 
Table 16 Time and pH of each sample during a simulated gastric acidification of Weet-Bix™  
control (W), Hayward kiwifruit + Weet-Bix™ (H+W), SunGold kiwifruit + Weet-Bix™ (S+W), 
granny smith apple + Weet-Bix™ (A+W), pepsin + Weet-Bix™ (P+W) and pepsin + Hayward 
kiwifruit + Weet-Bix™ (P+H+W) 
pH of sample 
Digestion time (min) 
W H+W S+W A+W P+W P+H+W 
Initial pH 
(at 5 min) 2 
5.4 3.7 3.7 4.1 5.3 3.6 
5.0 5.5 - - - 5.3 - 
4.5 6.5 - - - 6.5 - 
4.0 8.0 - - - 8.0 - 
3.5 9.5 6.7 7.0 8.8 9.7 6.5 
3.0 11.3 13.7 13.0 12.2 11.7 13.2 
2.5 13.3 20.0 19.0 16.0 13.8 19.8 
2.0 16.9 26.0 24.3 19.9 17.6 25.4 
                                                 
1 Test foods consisted of 41.8 g Weet-Bix™, 28 ml saliva, 100 g fruit pulp, 200 ml gastric salt 
solution and 7 ml 10% pepsin where applicable. Control had 100 g water substituted for fruit. 
2 Simulated gastric acidification commenced after 5 min of mixing. Samples were taken for DNS 
analysis at 5 min and at each 0.5 pH unit afterwards. Time at each sampling point was exported 




Figure 19 Mean starch digested (mg/g) (including fruit sugars where applicable) in test foods at 
different pH levels during a simulated gastric acidification. (A) Comparison between Weet-Bix™ 
control (W) and pepsin + Weet-Bix™ (P+W) that are similar in digestion digestion time at each 
sample pH. (B) Comparison between Hayward kiwifruit + Weet-Bix™ (H+W), SunGold kiwifruit + 
Weet-Bix™ (S+W), granny smith apple + Weet-Bix™ (A+W) and pepsin + Hayward kiwifruit + 






























































This study is the first to investigate factors underlying the glycaemic lowering effect of green 
kiwifruit on co-ingested starchy foods. The impetus for this work originated from a report by 
Mishra et al who speculated on mechanisms for a glycaemic-dampening effect of kiwifruit on 
starch (31). The current work was undertaken to elucidate the possible fruit related factors in 
glycaemic response to co-ingested cereal foods in light of the significant role of HSA in gastric 
digestion of starch recognised by Freitas et al (23, 60).  
 
 A semi-dynamic gastric model was developed for this project, involving automated titration at a 
physiological rate, which enabled mimicking of gastric digestion and analysis of HSA at a 
changing pH. The experimental results revealed that firstly, the low pH and strong buffering 
capacity of kiwifruit contributed to instant acidification of a food bolus causing acid inhibition of 
HSA. Secondly, organic acids such as citric acids in kiwifruit may inhibit HSA directly. Thirdly, 
kiwifruit actinidin degraded HSA at its optimal pH of 3.5-4.0 which was the pH of the fruit. The 
strong buffering capacity of both kiwifruit varieties (Hayward and SunGold kiwifruit) enabled 
prolonged effects of acid inhibition on HSA by delaying gastric acidification. The protease 
actinidin in Hayward kiwifruit resulted in additional inhibition by degrading HSA at its optimal pH 
around 4.0. However, the low pH of kiwifruit also promoted the activation of pepsin which 
degraded HSA as well as actinidin at pH 3.0 and below. Therefore, our experiments suggest 
that  kiwifruit is likely to promote retardation of gastric starch digestion by HSA through lowering 
gastric pH which enables acid inhibition and early activation of pepsin, additional partial 
suppression by citric acid as well as protease effect of actinidin (Hayward kiwifruit in particular). 
Moreover, it is plausible that a delay in gastrointestinal pH adjustment due to strong buffering of 
kiwifruit may impose a delay in GE which determines the rate that digestive contents enter the 
small intestine for glucose absorption. Overall, the above factors and their interactions may in 
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part explain the lowered glycaemic response to starchy foods when green kiwifruit is co-
ingested in an equal carbohydrate exchange format.  
 
5.1. Buffering capacity of various fruits 
 
The  buffering capacity of foods measured as titratable acidity has been claimed to have an 
impact on health conditions such as dental erosion in humans (87) and gut fermentation toxicity 
in livestock (88, 89). Our study partially filled a knowledge gap by investigating the buffering 
capacity of different fruits (i.e. kiwifruit, berries, apples and orange) during a simulated gastric 
digestion by titrating at a physiological rate.  
 
Based on the results of titration as shown in Table 6, the test fruits could be ranked as follows 
according to their buffering capacity in a simulated gastric acidification: SunGold kiwifruit > 
orange > Hayward kiwifruit > blackberry > raspberry > strawberry > granny smith apple > 
blueberry > pink lady apple. SunGold kiwifruit (the most buffering fruit) consumed nearly three 
times as much acid as Pink Lady apple (the least buffering fruit) in titrating to pH 2.0 despite a 
small difference in initial pH (0.2). Hayward kiwifruit consumed nearly twice the amount of acid 
as Granny Smith apple while having the same initial pH of 3.3. Therefore, the buffering capacity 
of fruits can vary considerably in spite of fruit pH. 
 
Granny Smith apple, Hayward and SunGold kiwifruit were further investigated as part of a 
cereal meal because of their similarity in fruit pH but disparity in buffering capacity. Granny 
Smith apple was chosen instead of pink lady apple because it is more commonly found in the 
market and stewed Granny Smith apple is a popular breakfast food. Mixing the three fruits with 
either Weet-Bix™ (Figure 8) or oats (Figure 9) reduced pH while increasing the buffering 
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capacity of both cereal foods in the order of SunGold kiwifruit > Hayward kiwifruit > Granny 
Smith apple, consistent with the buffering capacity of these fruits titrated alone. Mishra et al (31) 
demonstrated that nearly three times as much acid (0.5 M HCl) was used to titrate a meal that 
comprised of 200 g Hayward kiwifruit and 47.3 g Weet-Bix™ (pH 3.7) to pH 2.5 than Weet-Bix™ 
alone (pH 5.3). In our experiment, adding 100 g Hayward kiwifruit increased the acid 
consumption by 1.5 times as shown in Table 7.  
 
The level of organic acids is likely to be responsible for the difference in buffering capacity of 
fruits, as organic acids have been found to determine the acidity and buffering capacity in fruits 
(85, 86). A positive linear relationship was observed between levels of organic acids and 
buffering capacity, especially with acetic acid and citric acid (86). Citric acid is a common 
organic acid in fruits and is present in SunGold and Hayward kiwifruit; and in Granny Smith 
apples at the approximate concentration of 900, 970 and 26.4 mg/g, respectively (72, 110). 
However, citric acid contents can vary depending on orchard and storage condition after harvest 
as Marsh et al (70) reported that citric acid levels in kiwifruit decline during storage at 4°C.  
 
The effect of highly buffering kiwifruit on delaying gastric pH adjustment of cereal meals that 
was demonstrated in our study may slow down the rate that gastric chyme is emptied into the 
duodenum for further digestion and absorption as proposed by Mishra et al (31). Delayed GE 
has been claimed to be an underlying mechanism for the reduced postprandial glycaemic 
response to sourdough bread (28) and starchy foods with added vinegar (29), attributed to the 
presence of lactic acid and acetic acid, respectively. Therefore, it is plausible that citric acid in 
kiwifruit may delay GE and in turn reduce postprandial glycaemia as it is an organic acid.  
 
The research on buffering capacity of fruits has so far only scratched the surface as the food 
and meal components used in the experiment were simple. More in depth analysis of the effect 
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of fruit organic acids in complex meals containing other buffering components, for instance, 
milk, which is a common component of cereal meal is needed. In addition, the importance of 
fruit ripeness, which affect the level of organic acids and fruit acidity and the possibility of using 
pH adjusted fruit organic acids in controlling gastric pH and related digestive function are worthy 
of further investigation.  
 
5.2. Ca-KF buffer and pH inhibition of HSA 
 
Note that in the experiments investigating the effects of pH on HSA activity incubation was 
carried out in individual test tubes at different pH levels instead of taking continuous samples at 
different pH in one titration experiment because the latter method could produce another 
variable, reaction time which would be different between solutions with different buffering 
capacities.  
 
The Ca-KF buffer we developed contained similar concentrations of K and citric acid as in the 
kiwifruit and was diluted to reflect the change in concentration in titration (100 g pulp diluted with 
200 ml gastric salt solution). Citric acid is one of the main organic acids in kiwifruit and has been 
found to inhibit HSA due to its chelating effect, which reduces the availability of free Ca2+ ions 
required for HSA’s enzymatic function (52, 71). CaCl2 has been used for stabilising HSA in 
forensic saliva identification (71). CaCl2 (100 ppm) was found to enhance HSA activity and 
reduce peak starch apparent viscosity by 77% by Morris et al (111) and therefore was added to 
the buffer. Our result showed that HSA activity in the Ca-KF buffer was significantly lower than 
that in Ca-saline solution at a pH range of 6.0 to 3.0 (p<0.001), possibly due to the inhibition of 




There was a decreasing trend in HSA activity as pH decreased from 7.0 to 2.0 in both Ca-saline 
and Ca-KF buffer solutions (Figure 10) indicating a pH effect on HSA activity. A low pH of 3.0 
and below inactivated HSA as shown by little starch digestion at pH 3.0 and 2.0 in both 
solutions. Freitas et al (60) found that HSA exerted maximal activity at 6.2 and no activity at 3.0 
at 20 °C using potato starch. Fried et al (19) claimed that inactivation of HSA occurred at pH 
3.3-3.8 in vitro using an inhibitor assay. In our experiments, HSA had an optimal pH at 7.0, 
retained most of its activity at pH 4.0 (in Ca-saline solution) and was inactivated at pH 2.0.  
 
When incubated at the optimal pH of 7.0 over 60 minutes with either 50 µl or 100 µl saliva, 
starch digestion increased rapidly over 20 minutes followed by a plateau (Figure 11). A similar 
observation was made by Freitas et al (60) who found a plateau was reached by 15 min in an 
incubation at pH 6.0. Another increase in starch digestion was observed in our experiment at 60 
min which was not seen by Freitas et al (60). Ca-KF buffer was the buffer used throughout the 
experiments so its inhibition of HSA should always be taken into account.   
 
The gastric pH can be raised up to 5.5-6.5 by a solid-liquid meal and takes nearly 2 hours to 
return to the fasted state (pH 1.7-2.0) in healthy adults (25, 64). The pH of a normal meal is 
close to optimum for HSA activity so the enzyme can continue hydrolysing starch in the stomach 
until the pH drops to below 4.0 that may take up to 45 minutes (61). The gradual acidification 
process provides a window for HSA to hydrolyse about 59% and 76% of starch in mashed 
potatoes and bread, respectively, in the stomach (20). This prolonged starch digestion by HSA 
may be higher in people who have insufficient gastric acid secretion as Fried et al (19) found 
that HSA accounted for 27% of total amylase output in subjects with normal stomach function 
compared with 11% in achlorhydric subjects after a hamburger meal. Therefore, acidic fruits 
with strong buffering capacity like kiwifruit are likely to promote acid inhibition of HSA during oral 




The focus on citric acid in this study was because citric acid was known to inhibit HSA activity 
through both acid and chelating effect. It was therefore important to establish that the citric acid 
in kiwifruit did not have such a substantial inhibitory effect on HSA activity that it would be 
impossible to measure the effects of other factors such as pH and pepsin on HSA activity. While 
our study demonstrated that HSA activity could be measured in the presence of potassium and 
citric acid, in future research the buffer could be made to include a full range of kiwifruit organic 
acids, such as malic and quinic acids to give a more valid representation of kiwifruit juice.  
 
5.3. Pepsin inhibition of HSA 
 
Note that from this part onwards all pre-incubated samples were neutralised to eliminate the pH 
effect on HSA before carrying out starch digestion analysis. Therefore, starch digestion in the 
following context reflects the survival of HSA after pre-incubation. In addition, one ml saliva was 
used to increase starch digestion so that the effect of additional treatment would not be masked 
due to the pH sensitivity of HSA.  
 
As shown in Figure 12, the inhibition effect of pepsin on HSA was clear at pH 5.0 and below 
when compared to pH 6.0 and 7.0 where pepsin was inactive. No starch digestion was 
observed in samples pre-incubated at pH 2.0. One explanation could be that pepsin degraded 
HSA at its optimal pH. An alternative explanation could be that at pH 2.0, HSA could have been 
irreversibly inactivated. Previous studies as well as the SDS-PAGE results in this study revealed 
that pepsin could break down dietary proteins in the stomach once activated by HCl at low pH 
around 2.0 (77). Pepsin is most active at pH 1.5-2.0 and inactive at pH 5.0 and above (78, 79). 
However, 70% of peptic activity was found to be present at pH 4.0 in vitro by Pier and Fenton 
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(81).  Little was known about the direct effect of pepsin on HSA since gastric acidity was 
recognised as the major factor responsible for HSA inactivation in the stomach (15). However, 
one early study revealed that pepsin could contribute to a more extensive inhibition of HSA than 
HCl alone (82).  
 
Pepsin is unlikely to be active during the early stage of gastric digestion of a normal meal (pH 
5.5-6.5). However, if a food bolus containing kiwifruit can enter the stomach at a low pH (~pH 
3.5), it could possibly promote early activation of pepsin and further inhibit HSA activity in the 
stomach especially in people who are achlorhydric 
 
The limitation in this part of the experiment was a lack of control to clarify the complete inhibition 
of HSA at pH 2.0. Although the activity of HSA and pepsin as a function of pH has been 
extensively studied individually, conclusion on the inhibitory effect of pepsin will benefit from a 
comparison between control and the pepsin treated sample.  
 
5.4. Fruit inhibition of HSA 
 
A fruit sugar control was incubated at the sample condition as each fruit treated sample and the 
amount of fruit sugar was subtracted from the total reducing sugar measured by DNS to 
determine the amount of sugar released by HSA. A new pH point 3.5 was of interest because it 
was the pH of food bolus when Weet-Bix™ and oats were mixed with Hayward and SunGold 
kiwifruit in vitro.   
 
Pre-incubation with Hayward kiwifruit significantly inhibited HSA activity especially when the pH 
was below 5.0 (p<0.001) (Table 12). HSA activity was most inhibited by Hayward kiwifruit at pH 
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4.0 before complete acid inhibition at pH 2.0 (Figure 13). Actinidin, a natural protease abundant 
in Hayward kiwifruit might be responsible for HSA inhibition at this particular pH as it has been 
reported to actively degrade HSA at its optimal pH of 4.0 in one recent study by Martin et al 
(32).  
 
Pre-incubation with SunGold kiwifruit significantly reduced the activity of HSA at pH 3.5 and 
below (p<0.05) (Table 13) and the inhibition was most profound at pH 3.0 before the enzyme 
was denature by pH 2.0 (Figure 14). This may be a result of additional citric acid inhibition since 
SunGold kiwifruit was found to be more buffering possibly due to a higher concentration of citric 
acid compared with Hayward kiwifruit and Granny Smith apple. Degradation of HSA at pH 4.0 
was not observed in SunGold, which further suggests the effect of actinidin in Hayward kiwifruit 
as Hayward and SunGold kiwifruit are similar in nutritional composition, except that actinidin is 
abundant in Hayward but only found in trace amount in SunGold (74, 75). Gold kiwifruit has 
been used as a control for Hayward by Montoya et al to investigate the effect of actinidin on 
gastric protein digestion in vivo (34, 35).  
 
As shown in Figure 15, pre-incubation with Granny Smith apple resulted in little inhibition on 
HSA activity at pH 3.0 and below. Neutralisation of samples pre-incubated at pH as low as 3.0 
restored more HSA activity in apple treated sample than that in kiwifruit treated samples. This 
difference could be a result of lower citric acid level and absence of actinidin in the Granny 
Smith apple compared with the kiwifruit.  
 
Among three fruit treatments, Hayward kiwifruit inhibited HSA activity significantly more at a pH 
range of 7.0 to 2.0 than SunGold kiwifruit and Granny Smith apple. Inhibition was greatest at pH 
4.0 possibly due to the presence of the actinidin protease in Hayward. SunGold kiwifruit 
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contributed to a significant but smaller inhibition on HSA at pH 3.5 and below and Granny Smith 
apple had little inhibition on HSA along the pH range.  
 
A limitation of the research on actinidin activity against HSA was that in the titration experiments 
whole kiwifruit pulp was used compared with kiwifruit extracts used in this part of the 
experiment. Therefore, there was no absolute certainty that the inhibitory effects observed were 
due to actinidin alone. However, actinidin is known to be highly active in homogenised kiwifruit 
and almost absent in SunGold kiwifruit which was in consistency with our results. 
 
5.5. Pepsin and actinidin interaction in HSA inactivation 
 
The effect of actinidin and pepsin together on HSA activity was further investigated at a pH 
range from 4.0 to 2.0 because the pH of a food bolus was around 3.5 when kiwifruit was co-
ingested, because pepsin and actinidin are both proteases yet little is known about how they 
affected one another. Actinidin has been reported to have a broader specificity and pH range of 
activity compared with pepsin (83, 112). Hayward kiwifruit containing actinidin was found to 
enhance gastric digestion of large dietary proteins (MW>32 kDa) that were less digestible by 
pepsin (33-35) or when pH and pepsin concentration in the stomach are not optimal (36). The 
degradation of HSA by actinidin at pH 4.0 observed earlier was again seen in this experiment 
(Figure 16). Addition of Hayward kiwifruit further reduced HSA activity at 4.0 and 3.5 compared 
with pepsin treatment alone. Pre-incubation with pepsin alone resulted in complete inhibition on 
HSA activity at pH 3, while HSA pre-treated with pepsin and actinidin combined at this pH was 
able to digest around 300 mg/g (30%) starch once neutralised. It is possible that introducing an 




As there were three proteins (HSA, pepsin and actinidin) interacting with each other, SDS-
PAGE analysis was needed to provide direct insight into the observations described above. 
Analysis of pre-incubated samples by SDS-PAGE in Figure 17 A showed trends consistent with 
the results of starch analysis. In samples treated with pepsin alone, the HSA band disappeared 
at pH 2.0 and 3.0 and became clearer as pH increased from 3.5 to 4.0 in accordance with the 
results of starch analysis, in which no starch digestion occurred at pH 2.0 and 3.0 and more 
substantial starch digestion occurred at 3.5 and 4.0. In samples treated by pepsin and Hayward 
kiwifruit combined, both the actinidin and the HSA bands disappeared at pH 2.0, presumably as 
a result of active peptic activity at its optimal pH. At pH 3.0, although the HSA band was not 
visible, a thinner but clear actinidin band was present suggesting a weaker peptic activity at this 
pH. At pH 3.5 and 4.0, both HSA and actinidin bands were clear, indicating little peptic activity at 
higher pH. Overall, it is plausible that pepsin activity declines as pH increases and when there is 
more than one protein for it to digest.  
 
The interactions between pepsin, actinidin and HSA at pH 2.0, 3.0, 3.5 and 4.0 after 30 minutes 
of incubation at 37 °C were verified by a small scale experiment in Eppendorf tubes (Figure 17 
C). Pepsin bands were thicker in Figure 17 B, C, D because 5 mg/ml of more purified pepsin 
(3200-4500 U/mg protein) was used compared to 10% pepsin (>400 U/mg protein) in starch 
digestion. Pepsin in both assays had a final concentration of 800 U pepsin protein per ml. In 
addition, 40% kiwifruit was used instead of 50% kiwifruit to produce the same amount of protein 
as pepsin in order to be compared on SDS-PAGE. Despite this, the bands were almost identical 
between Figure 17 A and C.  
 
To further investigate which protease is more powerful under gastric conditions, actinidin was 
inhibited by its selective inhibitor E-64 and pepsin was inhibited by its selective inhibitor 
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pepstatin. Pepsin degraded both HSA and E-64 inhibited actinidin at pH 2.0 and 3.0 as shown 
by thinned actinidin bands (Figure 17 C). Actinidin actively degraded HSA at pH 4.0, but it did 
not degrade either active pepsin or pepstatin-inhibited pepsin at any pH (Figure 17 D). A kinetic 
assay that directly measured actinidin activity remained in the pre-incubated samples, providing 
confirmation that actinidin resisted pepsin digestion at pH 3.5 and 4.0 but was susceptible to 
pepsin digestion at pH 3.0 and below (Figure 18). This was in line with the in vitro finding by 
Donaldson et al (36) who found that actinidin had little effect when pH was below 3.1 during a 
simulated gastric digestion at changing pH (1.3-6.2) followed by a duodenal digestion at a 
constant pH of 6.4, suggesting that kiwifruit actinidin is more likely to have a protease effect in 
the stomach rather than the duodenum.  
 
On the contrary, the work of Rutherfurd and Montaya’s research team have demonstrated more 
than once that kiwifruit actinidin might pass through the gastrointestinal digestive track intact 
promoting protein digestion (33-35, 83, 113) even though our in vitro results have clearly shown 
that actinidin was highly susceptible to degradation by pepsin once the pH has dropped to pH 
2.0 and below (Figure 17 &18). Grozdanovic et al (114) who found that actinidin resisted 2 
hours of pepsin digestion even under ideal conditions for pepsin (pH 2.0) and therefore came to 
the conclusion that actinidin is capable of reaching the intestine mucosa intact. Grozdanovic et 
al (114) later demonstrated in mice that actinidin disrupted intestinal epithelium tight junctions 
and increased intestinal permeability causing food allergy. Bublin et al (115) also reported that 
20% actinidin remained intact after 1 hour of peptic digestion at pH 2.0. This supports the role of 
Hayward kiwifruit in gastrointestinal digestion of dietary proteins as observed in vitro (113) and 
in vivo (83).  
 
Our experiments revealed that pepsin and actinidin both could actively degrade HSA at their 
individual optimal pH. Pepsin degraded actinidin at its optimal pH but not vice versa. Thus, we 
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propose that during gastric digestion actinidin may degrade HSA at pH 4.0 and 3.5 where 
pepsin is not able to exert maximal activity. However, pepsin may degrade both HSA and 
actinidin when pH drops to 3.0 and below. However, further studies may be warranted to 
confirm our results due to the mixed findings in the literature illustrated above.  
 
5.6. Weet-Bix™ meal 
 
Starch digestion by HSA in a Weet-Bix™ meal under the effect of fruits (Hayward, SunGold 
kiwifruit and Granny Smith apple) and pepsin was analysed during a simulated gastric digestion. 
An average of 66% saliva per gram dry weight of Weet-Bix™ (28 ml saliva for 41.8 g Weet-
Bix™) was determined in a chewing test (Table 15). Due to a difference in buffering capacity, 
samples taken at the same pH might have been digested for a different length of time. 
Therefore, samples that were close in digestion time were compared in one graph. A similar 
amount of starch was digested during gastric digestion in both the Weet-Bix™ control and 
pepsin treated samples as shown in Figure 19 A, suggesting starch digestion could have been 
completed before sampling. Five minutes was the least time required to get ready for titration 
(steps including adding reagents in the order of Weet-Bix™, fruit pulps, saliva, pepsin, gastric 
salt solution and mixing; achieving a stable pH reading and a temperature of 37 °C). No 
difference in starch digestion between pepsin treated sample and control at pH 2.0 indicated a 
failure in pepsin activation. It took 6 min for the pH to drop from 3.0 to 2.0, which might not be 
sufficient for pepsin to activate and act on HSA. Most in vitro methods for gastric digestion either 
dissolve pepsin in HCl before adding or add pepsin after digesta has been acidified to pH 2.0 
(33, 60, 116). Moreover, peptic digestion at pH 2.0 was carried out for 30 minutes, while our 




Fruit sugar controls were not included in the fruit-cereal digestion which were designed to show 
the increase in starch digestion rather than the total amount of sugar released. Therefore, 
trends rather than the amounts of reducing sugars can be compared between treatments 
(Figure 19 B). Although variation was large, a similar trend can be observed between SunGold 
kiwifruit and Granny Smith apple treated samples, while the Hayward kiwifruit treated sample 
showed a different trend, possibly due to the presence of actinidin. A decreasing trend as pH 
decreased was observed in pepsin and Hayward combined treatment. Acidification of samples 
treated with pepsin and Hayward to pH 2.0 took 25 minutes which could be sufficient to activate 
pepsin at low pH and degrade HSA. Addition of Hayward kiwifruit halved the amount of starch 
digested by HSA in pepsin treated samples despite inclusion of kiwifruit sugar in the former. 
This may support our speculation that the kiwifruit can promote early pepsin activation and more 
complete pepsin digestion owing to its high acidity and strong buffering capacity.  
 
A major problem in this part of the experiment was the delay incurred during setting up the 
digestion of Weet-Bix™ in the presence of kiwifruit and pepsin. The current work has shown that 
starch digestion by HSA is rapid (< 5 min). In real life there are no delays between mastication, 
swallowing and emptying of the gastric chyme. Time did not permit, but priority should be given 
to streamlining the semi-dynamic digestion system for seamless operation.  
 
5.7. Strengths and limitations 
 
The strengths of our study include (1) development of a semi-dynamic gastric model consisting 
of automated titration which enabled acid/alkali dispensing at a physiological rate and analysis 
of the digestion medium at a changing pH; (2) the first to investigate the role of Hayward kiwifruit 
in glycaemic lowering in recognition of the significance of HSA in gastric starch digestion; (3) 
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step-wise investigation of the individual and combined effects of a number of factors (Ca-KF 
buffer – pH – fruits – pepsin – fruits and pepsin) on HSA activity in the stomach; (3) 
measurement of the effects of the above factors on HSA activity as a function of pH in 
recognition of the gradualness of the gastric acidification process; (4) filling a knowledge gap by 
investigating the buffering capacity of fruits in gastric digestion as well as interactions between 
pepsin, actinidin and HSA; (5) use of SDS-PAGE and actinidin kinetic assay as validation for the 
end-point starch analysis assay; (6) inclusion of an oral phase digestion using an estimated 
amount of saliva determined from a chewing test.  
 
Overall, the limitations of our study are: (1) adoption of simple meal components in titration 
experiments generating results that may have limited application to real-life complex meal; (2) 
use of one person’s saliva in experiments as HSA activity can vary among and within 
individuals; (3) lack of measurement of individual organic acid levels in fruits; (4) lack of a 
control for pepsin treatment in the study of the effect of pepsin on HSA activity; (5) uncertainty 
around the actinidin protease effect due to difference in fruit components used between 
experiments and meal study (kiwifruit pulp vs. kiwifruit extracts); (6) large standard deviations 
produced by natural lack of homogeneity in the fruit-cereal samples used in starch digestion; (7) 
lack of optimization to the meal study protocol due to insufficient time; (8) small sample size in 
most experiments due to insufficient time resulting in difficulty in conducting more vigorous 
statistical analysis.  
 
5.8. Conclusions and further directions 
 
To conclude, our project reveals that HSA is capable of rapidly digesting a considerable amount 
of starch at near-neutral pH which will be the pH of a starchy meal upon entering the stomach. 
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However, HSA is susceptible to low pH so that incorporation of acidic fruits, e.g., kiwifruit can 
result in immediate acid inhibition on HSA activity in the mouth and the strong buffering capacity 
of kiwifruit is likely to prolong the inhibition effect as food enters the stomach. Furthermore, HSA 
is susceptible to pepsin degradation at low pH (3.0 and below). Co-ingested kiwifruit is able to 
instantly acidify the food bolus to a pH level (~3.5) that promotes activation of pepsin. Hayward 
kiwifruit contains a natural protease actinidin that can actively degrade HSA at its optimal pH 
around 4.0 when pepsin cannot exhibit maximal activity. However, it is unclear whether 
inclusion of this extra protein actinidin has weaken the strength of pepsin when pH is not optimal 
for pepsin. When gastric pH falls below 2.0 HSA and actinidin is unlikely to resist pepsin 
degradation. In addition, the strong buffering capacity of kiwifruit, possibly owing to the high 
level of organic acids such as citric acid, is likely to delay GE and therefore further contribute to 
reduced glycaemic response to co-ingested starchy foods.  
 
There are a number of factors that can be optimized and investigated in further research. Firstly, 
the buffering capacity of fruits in more complex meal should be investigated with measurement 
of organic acid compositions included. Secondly, a full range of organic acids can be included to 
make up a buffer that represents kiwifruit juice. Thirdly, pepsin can be activated in HCl before 
adding into the digestion model and a longer period of digestion at pH 2.0 is needed. In addition, 
the interaction between pepsin and actinidin should be investigated under different pH. 
Moreover, other factors in kiwifruit should be considered and tested for, for instance, dietary 
fibre, which may play a role in GE by affecting gastric viscosity and particle breakdown (40, 65). 
Last but not least, future research with large sample size are needed to confirm the statistical 
significance of the above observations made in this study.  
 
Gastric digestion is an important link to intestinal digestion and absorption of starch. It is also a 
complex process where many factors come into play so their individual effect and interactions 
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need to be carefully examined to help understand the mechanisms underlying glycaemic 
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